ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[HMGB2, LRP2, GATA3, MEA1, GATA1, HOXA11, HOXA10, CTNNA1, PDGFRB, LHCGR, TGFB2, RRM1, BIK, INHBA, EIF2S2, ASPM, KITLG, SFRP2, NASP, MSH2, KIT, BCL2, BCL2L1]
GO:0007257;activation of JUN kinase activity;14.0;1.0;0.9759193652572005;9.628524252492122;8640.54909511404;6.088194173566533;0.2891914022241413;0.7872698984233759;[TNFSF11, CCL19, MAP4K1, SYK, RIPK2, CD40LG, MDFIC, PKN1]
GO:0090330;regulation of platelet aggregation;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;97.23557350837086;6.943860283624253;0.0032543871389904074;0.7513499630073597;[LYN, CEACAM1, SYK, PDPN, PRKCD, CD9, PRKCQ, ALOX12]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, CLU, ICAM1, PYCARD, TNFSF11, TRIM25, PRKCH, PRKCB, BTK, PRKCQ, ADAM8, S100A9, S100A8, CARD11, TNFRSF11A, PRKCZ, NLRP3, S100A12, TGFB1, EIF2AK2, NFKB1, NFKB2, MYD88, CD40, ITGB2, CD36, CHUK, RIPK2, IL18, IRAK3, TRAF1, GREM1, PSMA6, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:1900017;positive regulation of cytokine production involved in inflammatory response;8.0;1.0;0.875;9.628524252492122;226.66426644256094;7.004484905440688;0.0075862490132365176;0.7332096838060964;[CD6, TLR6, NOD2, TLR4, MYD88, IL17A]
GO:0002244;hematopoietic progenitor cell differentiation;4.0;0.811012628672052;0.655506314336026;8.935377071932177;21.066225782797595;5.395046993006588;7.050676185779127E-4;0.5259029541176994;[TOP2A, SPI1, TNFRSF13B, PLEK, SOX4, PDGFRA, ESCO2, TAL1, KIT, HOXB4, HOXB3, RBM47, PRKDC, PLD4, GATA3, JAM3, TGFB1, ACE, INHBA, ANLN, PTPRC, BCL2, PTPN6]
GO:0000188;inactivation of MAPK activity;13.0;0.8436909121759173;0.8844004208555951;9.558319993818873;2610.871803759405;6.518977089658987;0.08738352963975493;0.7959357562962344;[DUSP2, DUSP3, DUSP1, CAV1, DUSP6, DUSP10, PPP2R1A]
GO:0000186;activation of MAPKK activity;13.0;0.8259837884571596;0.8755468589962163;9.54300207905396;3706.2450018205795;5.845247994956144;0.12404468480698592;0.7614812190615239;[LRRK2, MAP3K8, GADD45B, EGF, F2R, EIF2AK2, ADAM9]
GO:0000184;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;10.0;0.8933024483968273;0.861892236059334;9.57851383191746;717.2549128915896;4.989581884898423;0.0240058764469685;0.6704084614939124;[PPP2R1A, MAGOH, GSPT1, UPF3B, NCBP2, EIF3E]
GO:0051088;PMA-inducible membrane protein ectodomain proteolysis;8.0;1.0;0.875;9.628524252492122;51.441664339349536;8.67846133901236;0.0017217062109458165;0.8188169164668168;[ADAM9]
GO:2000353;positive regulation of endothelial cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;6.943860283624253;0.00434501821119318;0.7513499630073597;[CD40, ITGA4, FASLG, THBS1, CD40LG, CCL2, PLCG1]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[IL10, CD274, CD96, IL33, NR1H4, LILRB1, INHBA, PDCD1LG2, GATA3, RARA, XCL1, PGLYRP1, TLR4, HAVCR2]
GO:2000473;positive regulation of hematopoietic stem cell migration;8.0;1.0;0.875;9.628524252492122;201.08518903965808;9.083926447120524;0.006730140312236458;0.839552420951524;[PTPRC, CCR2]
GO:0051402;neuron apoptotic process;5.0;0.8259837884571596;0.7032329060895001;9.022388448921806;23.44398779513952;6.113511981550823;7.846491732841165E-4;0.6028862989048107;[ADARB1, NAE1, CIT, BCL2, BCL2L1]
GO:0019800;peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan;9.0;1.0;0.896240625180289;9.628524252492122;433.4643727638907;7.9853141584524145;0.014507662463798891;0.8046099625986299;[SPOCK2, SPOCK3, BGN, DCN]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[, NUP107, PRKACB, CLDN3, PADI4, PDGFC, ABCA1, MCTS1, JUP, FN1, COL1A1, COL1A2, HLA-DRB1, ACHE, DPYS, ARHGAP6, CHAF1B, CHAF1A, KCND2, ARG1, F5, SLC7A7, SLC7A9, KCNA5, CENPA, HLA-DMA, HLA-DMB, DMD, CENPW, CENPE, CENPF, CENPH, CENPI, CENPK, CENPL, CENPM, GOPC, CENPN, CENPO, KCNG2, NCF1, GMNN, RUVBL2, RUVBL1, OLFM4, BLM, UQCRB, LIN7A, ACAT1, G3BP2, CXCL12, DMXL2, HLA-DRA, LRRK2, ALAD, VBP1, NDUFC2, ACPP, BDP1, BIRC2, BIRC3, NDUFB7, NDUFB6, HM13, NDUFB4, NDUFB3, NDUFB2, NDUFB1, CDC45, CCL5, EIF4H, NDUFA8, NDUFA7, NDUFA6, NDUFA3, NDUFA2, IL2RB, CD247, EIF3D, CCNH, PRF1, IKZF1, TCL1A, SNRPD2, SNRPD1, TNFSF11, FBXO5, SNRPD3, HNF1B, MIF, KCTD12, KCTD15, TGFA, PTK2, ANLN, CD40, CTSZ, CD3G, CD3E, CD3D, CCT3, CCT2, FCER1G, YAP1, NAPA, MIS12, CAPG, RXRA, CCT8, CD74, GCH1, RPA1, RPA2, RPA3, NDUFAB1, TGM2, NDUFB10, NDUFB11, TCF7, RASGRP1, CCNB1, LPXN, H1FX, ECT2, CAV2, UBE2C, CAV1, HMGA1, VIL1, NASP, UBE2S, TCF4, HMGB2, TNFAIP3, LAMC1, NUP62, GREM1, NDUFS8, NDUFS7, NDUFS6, NDUFS4, NDUFS3, NUP54, FBP1, TAF9, SAMHD1, RRM1, EGF, MX2, SOD2, TTC19, TEK, CDA, BIN2, ASF1B, NUP205, PRKCZ, ACMSD, HMOX1, NCKAP1L, EHD3, SERPINA1, CLINT1, TK1, BRD2, HCLS1, GSN, GTF2H1, HJURP, TNF, CLU, DACH1, OIP5, MEN1, TLE4, SNRPG, SNRPE, SNRPF, ITPR3, NACC2, LSM3, HOPX, SYNJ1, CDK1, PIK3C2A, PSTPIP1, EMILIN1, ADSL, VWF, TRAF1, PTBP2, MCM2, NLGN1, NLRC4, NOD2, PLN, WASF3, PML, MARCKS, RAD51, P2RX1, IMPDH2, PPP2R1A, MCCC2, COX7A2L, TLN1, MGST1, CD79B, CD79A, VASP, CDT1, AHCTF1, HBZ, RAD51C, UQCR10, AIF1, CTNNA1, NDUFA11, KNTC1, CHRNB4, NCF1C, ADRB2, NLRP3, MYH11, TGFB1, EIF2S1, H2AFX, AXIN2, CKAP5, DNM2, TGFBR3, COL6A2, COL6A1, COLEC12, CAMK2D, HIST1H2BK, LEF1, HSPD1, REPS2, POLQ, RBMX]
GO:1902564;negative regulation of neutrophil activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.92306413003195;8.390779266560578;0.00424800073309046;0.7800242071602487;[CD300A, FCGR2B]
GO:0007143;female meiotic nuclear division;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;65.96656019186406;7.069023426578259;0.0022078414035718876;0.7124295520356204;[PPP2R1A, TRIP13, MASTL, EREG]
GO:1902567;negative regulation of eosinophil activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.92306413003195;9.083926447120524;0.00424800073309046;0.8154717862087246;[CD300A, CCR2]
GO:0045652;regulation of megakaryocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.9575807315309;5.845247994956144;0.0023079481692908138;0.6498456195510879;[ITGA2B, HMGB2, THBS1, GATA1, NFE2, MEF2C, GP1BA, NR4A3, PRKCQ, MYL9, PF4]
GO:0046627;negative regulation of insulin receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;294.34753946768484;6.311337724880743;0.009851547250396369;0.6736814700148209;[PID1, CISH, PRKCB, PRKCD, TSC2, SLA2, PRKCZ, SOCS2, PTPRE, RPS6KB1, IL1B, PRKCQ]
GO:1902569;negative regulation of activation of Janus kinase activity;11.0;1.0;0.9324289523296623;9.628524252492122;1106.276363308231;9.777073627680469;0.03702607429583831;0.9324289523296623;[CD300A]
GO:0042149;cellular response to glucose starvation;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;115.90251486529202;6.063501560976162;0.003879152867050031;0.6610071170671804;[SESN3, UPP1, BCL2, SIK1, PIK3C3]
GO:1903538;regulation of meiotic cell cycle process involved in oocyte maturation;9.0;0.8933024483968273;0.8428918493787028;9.517298617381897;148.22274980760076;9.083926447120524;0.0049608820442461005;0.8607930461318132;[PPP2R1A]
GO:0001954;positive regulation of cell-matrix adhesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;50.25702962731741;5.926926025970411;0.0016820575532361247;0.6262235851885184;[NRP1, THY1, PRKCZ, EPB41L5, CCR7, CD36, JUP, CCL21, EMP2, CDK6, CEACAM6, NINJ1, TEK]
GO:0001836;release of cytochrome c from mitochondria;6.0;1.0;0.8231203125901445;9.628524252492122;22.134985108306864;6.686031174322154;7.408380313817617E-4;0.665044257777226;[JUN, BCL2A1, IFI6, BCL2, SFN, SOD2, CLU, BCL2L1]
GO:0001837;epithelial to mesenchymal transition;5.0;0.7508913569872202;0.6656866903545304;8.647694999480395;23.145667324477426;5.618190544320798;7.746646556020492E-4;0.5775555375700647;[LEF1, LOXL2, TMEM100, EPB41L5, FAM83D, EOMES, TGFB2, TGFB1, TGFBR3, BMP2, SNAI2, ENG]
GO:0031103;axon regeneration;7.0;0.8436909121759173;0.7727648213451592;9.427853557029971;96.50678923292918;6.832634648514029;0.00322999538515464;0.7003406189322132;[DHFR, JUN, CHL1, TNC, CTNNA1, BCL2, JAM3]
GO:0043923;positive regulation by host of viral transcription;11.0;1.0;0.9324289523296623;9.628524252492122;272.30213926078306;6.943860283624253;0.009113707545043459;0.7875382901567328;[JUN, LEF1]
GO:0035265;organ growth;3.0;0.7671156992804218;0.5816781622303554;8.753055515138222;22.582921643529833;6.444869117505266;7.558300640989654E-4;0.5277112189764278;[PDGFRB, PSAP, BCL2, DLL1]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, FCER1G, CHUK, SYK, FOS, GAB2, VAV1, LAT2, BTK, PRKCQ, LCP2, CARD11, PAK1, IGKC, IGLV1-44, PLCG2, PLCG1, LYN, JUN, NFKB1, NR4A3, IGKV3-20, LAT]
GO:0097192;extrinsic apoptotic signaling pathway in absence of ligand;7.0;1.0;0.8509193652572005;9.628524252492122;76.30875120206336;6.375876246018314;0.0025539852293156346;0.6769819729871445;[BCL2A1, DCC, IL1A, IL1B, BCL2, CASP2, BCL2L1]
GO:0046638;positive regulation of alpha-beta T cell differentiation;10.0;0.7671156992804218;0.7987988615011312;9.488762310116963;1285.3660192826185;5.970411137910149;0.04302004391107474;0.7205681151061569;[CD86, CD83, CD80, IHH, PRKCZ, HLX, MYB, NLRP3, NCKAP1L, CCL19, IL12RB1, ANXA1, SYK, RIPK2, IL18, ZAP70, IFNG, IL23A, RARA, NFKBID]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, ECM1, SERPINA1, SPARC, PROS1, ITGB3, ITGA2B, SERPINE1, PLEK, F13A1, CTSW, CLU, LAMP2, TIMP3, CD36, TIMP1, VWF, ACTN1, APLP2, ANXA5, ACTN4, F5, MMRN1, PECAM1, SERPING1, TLN1, VCL, CFD, STXBP2, PDGFA, THBS1, PSAP, FLNA, A2M, LYN, TGFB2, TGFB1, EGF, PCDH7, FN1, LHFPL2, PPBP, IGF1, SELP, TF, CD9, PF4]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, ITGB2, PLEK, ITGAL, CTGF, ADAMTS1, ITGAX, ITGB8, ITGB7, ITGB6, FCER1G, SYK, ITGA4, VAV1, FGR, HCK, CEACAM1, TYROBP, ADAM9, ITGA7, TLN1, CDH17, TXK, THY1, PTK2, COL3A1, ZYX, PLP1, LAT]
GO:0031339;negative regulation of vesicle fusion;7.0;0.8436909121759173;0.7727648213451592;9.392135474427892;149.70009243093662;7.9853141584524145;0.00501032737232711;0.7592887026755414;[CORO1A]
GO:0006933;negative regulation of cell adhesion involved in substrate-bound cell migration;6.0;1.0;0.8231203125901445;9.628524252492122;40.059981433445344;8.67846133901236;0.0013407715269347963;0.7669372290569613;[PTPRC]
GO:2000811;negative regulation of anoikis;8.0;1.0;0.875;9.628524252492122;103.9210822679579;6.943860283624253;0.0034781451006065307;0.7301093378270707;[CAV1, PTK2, CEACAM6, CEACAM5, BCL2, SNAI2]
GO:0048147;negative regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.87354995152188;6.409777797693995;0.0021377902344145586;0.6509166472493662;[CD300A, PAWR, NLRC3, DACH1, LTA]
GO:0046641;positive regulation of alpha-beta T cell proliferation;10.0;0.8653626801206646;0.8479223519212526;9.54628615425515;937.8544877713971;6.8867018697843045;0.03138914569146771;0.7674272657460779;[BLM, SYK, RIPK2, EBI3, IL18, CD3E, HLA-E, ZAP70, IL23A, CD28, XCL1, CCR2]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, JUNB, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, JAK3, HLA-DPA1, ANXA1, SERPINB2, IFNGR1, GPR35, RIPK2, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, ZEB1, PLCB1, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, STAT1, IL10RA, HLA-DPB1, PF4, CSF3, CSF3R, F13A1, IL5RA, RORA, CXCL13, TNF, PYCARD, IGHG1, MAP3K8, IL13RA2, IL13RA1, IFNA14, CISH, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, CD300LF, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, BCL2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, PIK3CD, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL2, XCL1, BIRC5, LCP1, BIRC2, BIRC3, CX3CR1, CEBPA, CEBPD, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, IL21R, CCL2, CCL1, FYN, FCGR1A, FCGR1B, PML, KLF6, IL2RB, PTPN6, IL1RN, IFITM1, IFI30, IFIT1, IFIT3, IFIT2, ICAM1, TNFSF11, TRIM25, RSAD2, ACSL1, IL1R1, IL1R2, HLA-B, FLT3LG, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IFI27, IL23A, EBI3, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, CD27, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, IL10, SYK, IL15, IL18, GP1BA, GAB2, IL17RB, VAV1, HCK, IL1A, CEACAM1, IL1B, KIT, RHOU, SP100, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR3, CXCR2, IL32, CD74, IL33, OSM, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, ISG15, NFKBIA, IL6, IL7R, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, LMNB1, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, IRF8, LTB, CAMK2D, SAMHD1, NCAM1, MX2, SOD2, CD4, LTBR]
GO:0006816;calcium ion transport;8.0;0.6696747006330769;0.7098373503165385;8.690254613899192;35.67391733828006;4.3132418226548594;0.001193973908871026;0.5955793873968269;[DENND5B, PHB2, SLC8A1, CTGF, PRKCE, F2R, CACNA2D3, CALCRL, CUL5, PSEN2, ITPR3, CACNA1F, CORO1A, PLCG2, CCR1, VDR, CAV1, BSPRY, PTPRC, ATP2A3, FASLG, JPH2, CCR7, CCR5, TRPC7, TRPC3, TRPC1, TMEM37, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, ATP2C2, CCL8, PLN, CCL5, NPY, FYN, CCL19, CCL21, FKBP1B, RAMP1]
GO:2000134;negative regulation of G1/S transition of mitotic cell cycle;9.0;0.7980440201809971;0.7952626352707877;9.394909401310617;355.88113835876356;5.244474134527214;0.011911021428637128;0.6644432763129993;[CDKN1A, BTG2, CASP2, SOX4, CDC25C, TFDP1, PCNA, PRKDC, AURKA, CCNB1, GPNMB, NACC2, E2F1, CCL2, SFN, E2F7, E2F8, PLK2, RPA2, KLF4, PML, CNOT3, CDK2, CDK1, BCL2, EZH2]
GO:0033630;positive regulation of cell adhesion mediated by integrin;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.61675044652454;6.943860283624253;0.0011585914843924019;0.6453503496879909;[TGFB2, SFRP2, SYK, CCL21, CCL5, ADAM9, NCKAP1L, PTPN6, CXCL13]
GO:0051549;positive regulation of keratinocyte migration;9.0;1.0;0.896240625180289;9.628524252492122;297.9389118084288;7.697632086000634;0.009971747250615804;0.7898978880348613;[EPB41L4B, ADAM9, MMP9, HBEGF]
GO:0051306;mitotic sister chromatid separation;4.0;1.0;0.75;9.628524252492122;27.51648075733887;8.67846133901236;9.20951847723215E-4;0.6938169164668168;[PPP2R1A]
GO:2000378;negative regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;113.12708673636307;5.905872616772578;0.003786261785297929;0.6251469128630576;[HP, BRCA1, SLC30A10, CD34, IL10, CAV1, PAX2, BCL2]
GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;10.0;1.0;0.9152410118609203;9.628524252492122;570.2036429558796;6.221725566191056;0.019084202779771145;0.7334203466557586;[CX3CR1, STRADB, IFI6, TNF, GATA1, IL1A, IL1B, CTNNA1, BCL2, AKT1, SNAI2, FYN, PF4, BCL2L1]
GO:2001241;positive regulation of extrinsic apoptotic signaling pathway in absence of ligand;10.0;1.0;0.9152410118609203;9.628524252492122;424.359905324836;7.292166977892469;0.01420294413210246;0.7881627702307852;[SRPX, PPP2R1A, CTNNA1, INHBA, PPP1CA]
GO:0033077;T cell differentiation in thymus;7.0;0.8653626801206646;0.7836007053175329;9.420884887713877;66.99450330244977;6.481236761676141;0.002242245734394454;0.6823701146576509;[BCL11B, FZD5, PRKDC, FZD8, MAFB, DNAJA3, BCL2, CCR6]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[BLK, ITK, TXK, SLA, SLA2, GRAP2, FYN, CSK, JAK3, LYN, SYK, MATK, BMX, PTK2, FGR, ZAP70, HCK, LCK, FES, BTK]
GO:0043375;CD8-positive, alpha-beta T cell lineage commitment;6.0;1.0;0.8231203125901445;9.628524252492122;44.46807846579176;9.777073627680469;0.0014883065675776633;0.8231203125901445;[BCL2]
GO:0006275;regulation of DNA replication;7.0;0.6144040707577935;0.6581214006360973;8.623002386890024;150.73814970462044;5.142344639450834;0.005045070215086414;0.6138991092621975;[SMARCAL1, EHMT2, DSCC1, GMNN, BRCA2, SMC3, DACH1, PPP2R1A, RFC5, RFC3, TIPIN, RFC4, RFC2, ESCO2, SMC1A, EREG, MSH6, DBF4, MSH2, TIMELESS, DNA2, BLM, PCNA, CST3, E2F7, S100A11, E2F8, CDT1, JUN, DONSON, CDC7, CDC6, STAG2, BCL6, CDK2, CDK1]
GO:0070050;neuron cellular homeostasis;5.0;0.7980440201809971;0.6892630219514189;9.089527751759436;31.94563669038233;7.292166977892469;0.0010691917108206317;0.6631627702307852;[NELL2]
GO:0010523;negative regulation of calcium ion transport into cytosol;9.0;0.8259837884571596;0.8092325194088689;9.417215158824915;155.07739949607335;6.943860283624253;0.00519030100053507;0.7513499630073597;[TGFB1, FKBP1B, BCL2, CALM3]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, ICAM1, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, SIRPA, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, DOK2, PRTN3, ADAM8, S100A9, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, FUT7, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, ESAM, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, PIK3CD, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, PDE4D, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, SLC7A9, IL1B, CEACAM5, KIT, PECAM1, XCL2, XCL1, CD48, CEACAM8, CX3CR1, CCL13, SELPLG, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR3, TBX21, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, F2RL1, PTPN6, TEK, CD244, PF4]
GO:0030595;leukocyte chemotaxis;6.0;0.6873818243518346;0.6668112247660618;8.768322987269011;62.06300720445581;4.857092701852345;0.002077192998052941;0.5715122592407831;[CXCL6, CXCL9, IL1RN, CSF3R, ITGB2, PIK3CD, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, CXCL16, LGALS3, EDNRB, PDE4B, TNFSF11, FFAR2, CCR7, CCR6, CCR5, IL6R, CCR2, IL10, CXADR, ANXA1, FCER1G, SYK, PDE4D, VAV1, CH25H, IL1B, KIT, XCL2, XCL1, ADAM8, S100A9, S100A8, CX3CR1, CCL13, CALCA, C5AR1, CXCR5, CXCR4, TNFRSF11A, CORO1A, CCL8, CXCR1, CCL7, NUP85, CCL5, CXCR3, CXCR2, CCL4, CCL2, S100A12, CCL1, NCKAP1L, CCL19, CCL18, CCR1, CCL23, TGFB2, CCL21, CCL20, AZU1, DEFA1, PPBP, CXCL10, CXCL11, IL6, PF4]
GO:0030111;regulation of Wnt signaling pathway;6.0;0.5902001590945054;0.6182203921373972;7.99439372746765;41.8512380110395;4.069963362931594;0.0014007232725606145;0.5312584282431182;[PPP2R1A, RUVBL2, RUVBL1, SOX7, SOX4, WLS, TLE4, RNF43, TSC2, HNF1B, SFRP4, DEPDC1B, SFRP2, DAAM2, NAIP, APCDD1, FOXO1, FZD1, EGR1, JUP, FZD5, CAV1, NFKB1, COL1A1, BMP2, DAB2, GNAQ, SNAI2, CDK14, LRRK2, TNFAIP3, HHEX, AXIN2, AES, GREM1, ASPM, MDFIC, PFDN5, TLR2, YAP1, LRP1, LEF1, FRZB, CTHRC1, EGF, TMEM64, MAPK14, SULF1, PPP1CA, SULF2, LGR4]
GO:0070059;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.12593595584649;6.343086423195323;0.002815619368015229;0.6753050999230941;[PPP1R15A, CEBPB, TNFRSF10B, PML, BCL2]
GO:0033625;positive regulation of integrin activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;140.3817219977405;8.16763571524637;0.004698449899916962;0.7686126355688037;[PLEK, CXCL13, CDH17]
GO:2000147;positive regulation of cell motility;6.0;0.5781283279524737;0.6121844765663813;8.052987891733702;115.84051076538883;3.630744370011572;0.0038770776456263385;0.5087967485194164;[SPARC, SERPINE1, MYLK, ICAM1, LGALS3, C3AR1, AKT1, IL1R1, PRKCE, ACTN4, IL23A, CLDN7, PFN1, KIF20B, TWIST1, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, IGF1, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, ANXA1, ANXA3, GAB1, TACR3, SIRT1, F3, IL1A, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, AIF1, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CD74, CCL21, CCL20, F2RL1, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, ETS1, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, POSTN, SEMA6A, IGFBP5, F2R, ADAM9, ADAM8, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, VIL1, CXCL10, CXCL11, IL6, BMP2, DAB2, CXCL12, PTPRC, NR4A3, BCL2, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, PIK3CD, LAMC2, CXCL1, CXCL3, PIK3C2A, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL2, XCL1, LEF1, THBS1, P2RY6, CCL8, CCL7, CCL5, SPOCK2, CCL4, CCL1, SEMA4A, EGF, SEMA4B, LAMB1, MAPK14, SOD2, RPS6KB1, TEK]
GO:0008380;RNA splicing;8.0;0.7248374789738407;0.7374187394869203;9.182237149863703;117.47952805794706;3.8501476017100584;0.003931934079388465;0.5718967274016261;[LGALS3, SNRPD2, PPP2R1A, SNRPD1, MAGOH, SNRPD3, MBNL2, UPF3B, FMR1, SNRPG, SNRPE, SNRPF, SNRPA, LSM5, LSM3, NCBP2, ESRP1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, RBM38, ACIN1, RBMX]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[ITGB5, PTPRK, ARRB2, F11R, CDH5, FOS, SIRT1, TGFBR3, ADAM9, LTBP2, PRKCZ, JUN, TGFB2, TGFB1, USP9Y, PTK2, PML, COL3A1, COL1A2, ID1, ZYX]
GO:0043666;regulation of phosphoprotein phosphatase activity;9.0;0.7436939687323844;0.7680876095464813;9.328419660041783;158.30216566976694;5.058574756385375;0.005298231022267458;0.6549363734696205;[TNF, PPP2R1A, PDGFRB, PPP1R16B, PPP1R12A, CD300A, FCRL3, IGFBP3, MASTL, PPP1R15A, GNAI2, NCKAP1L, EIF2AK2, FKBP1B, CALM3]
GO:0043305;negative regulation of mast cell degranulation;11.0;0.9326813400603323;0.8987696223598284;9.607470843294289;1077.1478631716955;7.9853141584524145;0.03605116961021663;0.8407982897480031;[CD300A, HMOX1, IL13RA2]
GO:0045843;negative regulation of striated muscle tissue development;7.0;0.7140352122741334;0.7079369713942671;9.0094850440859;170.02370427431143;6.015873511986907;0.0056905403706616975;0.6585714164269392;[MYOCD, TGFB1, LEF1, TWIST1, DLL1, PAK1, MEIS1, BMP2, EPHB1]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[IL1RN, CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, PDGFRA, CXADR, PRKCD, CH25H, HOXB9, BIN2, AGTR1, PRKCQ, ADAM8, S100A9, S100A8, EPHA2, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, S100A12, NCKAP1L, CCR10, CCR1, TGFB2, EGR3, VCAM1, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, IL6, CXCL12, NRP1, CXCL6, CXCL9, DOCK4, ITGB2, HMGB2, PIK3CD, CXCL1, ARRB2, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR3, CCR2, IL10, ANXA1, FCER1G, SYK, PDE4D, RHOG, GAB1, VAV1, IL1B, KIT, XCL2, XCL1, HBEGF, CX3CR1, CCL13, LEF1, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR3, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, PF4]
GO:0030866;cortical actin cytoskeleton organization;6.0;0.7671156992804218;0.7066781622303554;9.117698628726131;53.946853691669205;6.088194173566533;0.0018055526440439148;0.63447084575632;[PLEK, TNF, RACGAP1, EPB41L3, NCKAP1L, PLS1, KIF23, VIL1, ANLN, TLN1, LLGL2]
GO:0051044;positive regulation of membrane protein ectodomain proteolysis;9.0;1.0;0.896240625180289;9.628524252492122;964.0127980139503;7.069023426578259;0.03226464079433516;0.757750811958709;[IFNG, IL1B, ADAM9, ADAM8, TNFRSF1B, TNF]
GO:0030509;BMP signaling pathway;11.0;0.7090535922965819;0.7869557484779532;9.133828010656014;282.55034729266697;5.202362649177086;0.009456705845082177;0.6984780201431826;[LEF1, FSTL1, TMEM100, EGR1, TGFB2, TGFB1, USP9Y, RUNX2, RGMA, TGFBR3, BMP2, ZFYVE16, ID1, ENG]
GO:0072540;T-helper 17 cell lineage commitment;8.0;1.0;0.875;9.628524252492122;46.25983793501841;7.9853141584524145;0.0015482751445338478;0.7833693374183408;[IL6, LY9]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFITM1, PRF1, ADARB1, IFIT1, IFIT3, IFIT2, PYCARD, HERC5, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, DDX60, NLRP3, IFNA21, EIF2AK2, ISG15, AZU1, DEFA1, CXCL10, IL6, PTPRC, BCL2, SERINC5, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, DDX58, PARP9, PLSCR1, IFNG, OAS1, OAS3, IRF7, TLR8, TLR7, ZMYND11, EXOC1, UNC93B1, SAMHD1, IL33, STAT1, MX2, CARD9, LILRB1, PML, F2RL1]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[SUV39H2, SUV39H1, MPL, RORA, PHB2, SLC8A1, AQP1, ICAM1, AKT1, EDN1, KCND2, PRKCE, SIRT1, CCNA2, ADAM8, TWIST1, PTGS2, CCNB1, BRIP1, E2F1, HMOX1, FABP1, BCL2]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, LRRK2, CETN3, CALML4, SLC8A1, GRM5, EDNRB, CCRL2, CCR9, TNFSF11, CCR7, CCR6, CCR5, CCR3, CCR2, EDN1, AVPR1A, ATP1B1, LAT2, BTK, AGTR1, CX3CR1, CAMK2D, CXCR5, CXCR4, FPR2, CXCR6, PLN, CXCR1, CXCR3, CXCR2, PLCG2, DMD, PLCG1, CCR10, CCR1, VCAM1, CCL20, AZU1, SELE, SELP, FKBP1B, CALM3, LAT]
GO:2001243;negative regulation of intrinsic apoptotic signaling pathway;9.0;0.7436939687323844;0.7680876095464813;9.413412872875176;597.3701724921605;5.233778845410465;0.0199934420750612;0.663896318730187;[LRRK2, CLU, AKT1, GPX1, PLAUR, MIF, MMP9, SIRT1, SFRP2, NDUFS3, BCL2A1, TAF9, PTGS2, FIGNL1, CD74, WFS1, SOD2, VNN1, CXCL12, BCL2, SNAI2, GRINA, BCL2L1]
GO:2001244;positive regulation of intrinsic apoptotic signaling pathway;9.0;0.7671156992804218;0.7797984748205;9.413412872875176;596.4251749563025;5.75172193694532;0.019961813857978603;0.6903839525180965;[PLEKHF1, NACC2, CAV1, SIRT1, LCK, BCL2, S100A9, ATF3, S100A8, NOX1, BCL2L1]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, LYL1, HHEX, LGALS1, BLNK, JAK3, TPD52, IL10, CR2, IFNA14, ITGA4, IFNA16, NFAM1, ATP11C, MSH2, KIT, CDH17, CARD11, IFNA10, DLL1, CD79B, CD79A, PLCG2, NKX2-3, IFNA21, VCAM1, KLF6, CD40LG, BCL6, BCL3, FCGR2B, ITM2A]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRA, EDNRB, GPR171, C3AR1, AKT1, PROK2, HOMER3, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, TIAM2, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, PIK3R5, C3, GNG10, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD2, FZD5, OR2J2, FZD8, AZU1, NMBR, PPBP, GNG11, MARCO, PNOC, CALM3, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, ADM, CD3E, AKAP12, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR3, CCR2, EDN1, GPR37, ANXA1, GPR35, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, PLCB1, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR3, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, F2RL1, RAMP1, LGR4, F2RL3, PF4, CHRM2, FCN1, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, CISH, SPNS3, APLP2, F2R, NPY1R, DGKZ, PDGFRL, ADCYAP1, SPNS1, OR2C3, GNAZ, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, ITPR3, GPR84, ADRB2, GPR82, HRH4, PSAP, ECT2, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, GNAQ, OR7E24, TAS2R7, CXCL6, GPSM2, CXCL9, OR1G1, PLEK, CXCL1, ARRB1, ARRB2, CXCL3, CXCL2, CXCL5, LTB4R, GRM5, CA2, PDE4B, PTGIR, ARHGEF12, PDE4D, GLP2R, OR2H1, XCL2, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, GNA15, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0014031;mesenchymal cell development;4.0;0.8653626801206646;0.6826813400603323;9.474373572664863;32.15320660831846;6.409777797693995;0.001076138889173156;0.5777963346592216;[EDN1, JAG1, EDNRA, BCL2, SNAI2]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IL10, IFNA4, IFNA7, MEF2C, CR2, CD40, IFNA14, IFNA16, IFNA2, CD180, PRKCD, LEF1, IFNA8, HSPD1, CD79A, CD40LG, PTPRC, BCL2, IL7R, MS4A1, CARD11, IFNA21, IFNA10]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PGLYRP1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, NRAS, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, NPC2, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CTSD, CAMP, CD33, CTSB, CD53, CCT2, FCER1G, MME, GAA, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CD300A, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, GGH, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, DOCK2, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, JAK3, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, RIPK2, IL15, IL18, PDCD1LG2, HLA-E, ZAP70, IL23A, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, EBI3, CD1D, CORO1A, AIF1, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, VCAM1, LILRB2, IGF1, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, CD28, HLA-DPB1, CD24]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[SPARC, TFRC, CLEC10A, ICAM3, KIAA1109, DPYSL2, CUBN, SLC11A1, HSPG2, RIN2, CFI, FPR2, CD14, IGHA1, ELANE, SLAMF1, MSR1, CDC7, MARCO, DENND1B, ACHE, ADM, CLINT1, ASGR1, ASGR2, STAB1, CD36, ANXA1, FCER1G, SYK, ANXA3, NME1, CEACAM1, RARA, RHOU, CD302, CD5L, TMPRSS2, IGKC, CXCR1, CXCR2, SORT1, LILRB1, SNX17, NEDD4, SIGLEC1, RAMP1, SCARB2, NCF2, NCF4, HP, LY75, CXCL16, LOXL2, PYCARD, AP2M1, TGM2, CD93, TSC2, RAB31, PRTN3, CALCRL, PLD4, ADRB2, CORO1A, IGLV1-44, CD163, SYT2, CAV2, CAV1, LRP1B, MARCH3, DAB2, SYNJ1, IGKV3-20, LRP12, BCL2L1, LRRK2, ITGB3, ITGB2, ARRB1, ARRB2, ITGAL, PIK3C2A, GHR, PSTPIP1, ITGA4, DNM2, PECAM1, IRF8, PIK3C3, DOCK2, COLEC12, NLGN1, LRP1, CEBPE, LRP2, DLL1, FCGR1A, FCGR1B, ATP9A, SNCA, NLGN4Y, CD6, CD5, CD9, FCGR2B]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[SCARB2, SPARC, TFRC, HP, CXCL16, LOXL2, AP2M1, CUBN, HSPG2, RAB31, CALCRL, CFI, FPR2, ADRB2, IGLV1-44, CD14, IGHA1, MSR1, CD163, CAV2, CAV1, LRP1B, MARCO, DAB2, SYNJ1, IGKV3-20, LRP12, ACHE, ITGB2, ADM, ARRB1, ARRB2, ASGR1, ASGR2, STAB1, CD36, FCER1G, SYK, ITGA4, DNM2, CEACAM1, COLEC12, LRP1, CD5L, TMPRSS2, LRP2, DLL1, IGKC, CXCR1, CXCR2, FCGR1A, FCGR1B, SNCA, LILRB1, CD6, SNX17, CD5, NEDD4, CD9, FCGR2B, RAMP1]
GO:0045063;T-helper 1 cell differentiation;11.0;1.0;0.9324289523296623;9.628524252492122;473.70362526189734;8.16763571524637;0.01585443403193107;0.8501222226412654;[SEMA4A, LEF1, IL18R1, RELB]
GO:0030854;positive regulation of granulocyte differentiation;9.0;0.8653626801206646;0.8289219652406215;9.510741216835738;841.2946472498035;7.697632086000634;0.028157374727424533;0.7898978880348613;[LEF1, HCLS1, TRIB1, EVI2B]
GO:0051973;positive regulation of telomerase activity;9.0;0.9326813400603323;0.8625812952104552;9.600353375525426;952.4250073221435;6.193554689224359;0.031876807868214944;0.7129793000169707;[AURKB, NEK2, CCT4, CCT2, NEK7, KLF4, GRHL2, GREM1, PRKCQ]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[CD40, TNFRSF13B, TNF, TNFSF13B, PYCARD, TNFSF11, CHUK, TNFRSF1B, LTA, LTB, BIRC2, BIRC3, TNFRSF11A, TNFRSF17, TNFSF14, STAT1, TNFSF12, TNFSF13, TNFRSF10C, TNFRSF10B, NFKBIA, CD40LG, CD27, LTBR]
GO:0001755;neural crest cell migration;6.0;0.7980440201809971;0.722142322680643;9.089527751759436;22.57397290845719;5.825829909099042;7.555305579894227E-4;0.6210535250702663;[NRP1, SEMA5B, SEMA4A, SEMA6A, SEMA4B, LEF1, TWIST1, EDNRB]
GO:0001756;somitogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;43.80328827915336;5.845247994956144;0.0014660566383032007;0.5891672661548076;[PRKDC, LEF1, AXIN2, DLL1]
GO:0045860;positive regulation of protein kinase activity;10.0;0.6281612110245125;0.7293216173731766;9.003430535177193;1094.9224192180604;3.5309668621989068;0.03664606800502658;0.5958148214005239;[, IL1RN, CCNH, CCNC, TCL1A, AKT1, PROK2, TNFSF11, PRKACB, ACSL1, SLC11A1, PRKCD, MIF, EREG, PRKAR1B, IL23A, FPR1, TGFA, PDGFA, IQGAP3, PRKCZ, PIK3R5, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, EGR1, ACE, FZD5, GADD45B, FZD8, EIF2AK2, CDC6, AZU1, IGF1, PTK2, TPX2, NOX4, CALM3, CD24, EZH2, CDKN1A, CD40, KIF14, CCR7, MAP4K1, EDN1, SYK, RIPK2, STRADB, IL18, EMP2, SIRT1, DUSP6, MDFIC, IL1B, KIT, CKS2, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD74, CCL21, CENPE, CD40LG, PKN1, CAMK1, CCNT2, NCF1, TNF, CLU, MAP3K8, IL6R, PDGFRB, MAP2K2, F2R, ADCYAP1, ADAM9, ADAM8, CSF1R, CALCA, C5AR1, TNFRSF11A, ADRB2, RASGRP1, CCNB1, STAP1, CLSPN, ECT2, DRD4, MAP2K6, TGFB2, TGFB1, TNFRSF10B, GH1, BMP2, PTPRC, CDK1, CSPG4, LAT, LRRK2, ITGB3, ARRB1, CYR61, CKS1B, GHR, GRM5, GREM1, PSRC1, IFNG, CHI3L1, LCP2, PDE5A, LTF, NOD2, THBS1, CCL5, FYN, CSK, SNCA, EGF, MAPK14, CD4]
GO:0070233;negative regulation of T cell apoptotic process;10.0;0.8259837884571596;0.8282329060895002;9.370695143190021;155.57980234840144;6.7325511899570465;0.005207115971869279;0.7595439928109722;[BLM, SLC46A2, CCL5, CD27, PRKCQ, IL7R, JAK3]
GO:0002728;negative regulation of natural killer cell cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;694.1135629292197;9.777073627680469;0.023231356289590815;0.896240625180289;[CD96]
GO:0032233;positive regulation of actin filament bundle assembly;10.0;0.8933024483968273;0.861892236059334;9.533214072687796;256.92976895603965;5.734022359845919;0.008599208145178776;0.7084791820027498;[NRP1, SYNPO2, PLEK, ARHGEF10L, CTGF, PAK1, FLNA, TPM1, VIL1, ID1, NOX4, PFN1]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, CSF3, NCF1, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, FAM3D, EPHB2, PHLDA2, MED1, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IL23A, NBL1, IFNA10, CALCA, EBI3, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, IGF1, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, FBN1, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, SECTM1, CXCL1, FASLG, ADM, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, TNFSF12-TNFSF13, IL10, EDN1, IL15, PDE4D, IL18, GREM1, IL1A, IFNG, IL1B, LTA, XCL2, XCL1, LTB, SHANK3, HBEGF, CCL13, NLGN1, GRN, CLEC12B, RETN, TYMP, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, SPP1, CCL2, CCL1, CCL19, CCL18, IL32, CMTM8, IL33, CCL23, CCL21, EGF, CCL20, OSM, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0033689;negative regulation of osteoblast proliferation;6.0;1.0;0.8231203125901445;9.628524252492122;63.18040277096193;7.57984905034425;0.0021145912220731796;0.710754145523778;[GREM1, BCL2, EIF2AK2]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, F11R, ICAM1, ANPEP, CLEC5A, ITGB7, ITGB6, HAVCR1, CTSB, CR2, CR1, CXADR, EPHA2, GYPA, SELPLG, DPP4, NCAM1, SLAMF1, GPR15, CDK1]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, LST1, ICAM1, EPS8, TPM1, VRK1, CSF1R, EPB42, ARHGAP15, CORO1A, SPTA1, EPB41L3, MYH14, MYH10, FN1, CDC7, PARVB, PTK2, VIL1, FES, PLXNB2, ITGB2, ANXA1, RHOG, ARAP3, RHOH, ARAP1, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD3, FGD4, CCL7, PDPN, CCL2, FYN, WASF3, SEMA4A, DLC1]
GO:0060101;negative regulation of phagocytosis, engulfment;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;308.4024909144947;9.777073627680469;0.010321953826686011;0.896240625180289;[CD300A]
GO:0043320;natural killer cell degranulation;9.0;1.0;0.896240625180289;9.628524252492122;133.05394577034187;8.16763571524637;0.004453195824156379;0.8139338954918922;[CORO1A]
GO:1904837;beta-catenin-TCF complex assembly;5.0;1.0;0.7902410118609202;9.628524252492122;40.42272244673708;6.409777797693995;0.0013529121422039536;0.618037346520142;[TLE4, LEF1, TCF7, AXIN2, RUVBL1, MEN1]
GO:0045744;negative regulation of G-protein coupled receptor protein signaling pathway;7.0;0.6467165523344657;0.6742776414244334;8.623002386890024;189.85671913105512;6.166155715036245;0.006354333529362364;0.6662568552797195;[, PLEK, ADRB2, ARRB2, GNAI2, CCL5, STMN1, SNCA]
GO:0001960;negative regulation of cytokine-mediated signaling pathway;7.0;0.7140352122741334;0.7079369713942671;8.965230035081857;244.80256319284138;5.8067817141283475;0.008193321482061134;0.6478784521606894;[ECM1, IL1RN, CCL5, STAP1, ARG1, NR1H2, IL1R2, CAV1, NR1H4, IRAK3, MMP12, IL6, PTPRC, PXDN, PADI2, F2RL1]
GO:0002378;immunoglobulin biosynthetic process;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;39.16312370347755;9.083926447120524;0.0013107545058323288;0.7547934328124444;[PTPRC]
GO:0070262;peptidyl-serine dephosphorylation;8.0;1.0;0.875;9.628524252492122;179.24922260518233;7.292166977892469;0.005999310166768488;0.747921758369865;[PPP2R1A, DUSP1, PPP1CA]
GO:0030845;phospholipase C-inhibiting G-protein coupled receptor signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.976932752798508;9.777073627680469;9.028936615729279E-4;0.8231203125901445;[PLEK]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CDKN1A, FOXM1, PPP2R1A, NEK2, SKP2, TUBG1, MASTL, CDC25C, CKAP5, CDC25A, CIT, DNM2, CCNA2, MELK, PLCB1, PKMYT1, AURKA, CCNB2, CCNB1, PRKAR2B, CEP72, CEP76, PLK4, CEP152, PLK1, WEE1, CDK2, CDK1, CDK14]
GO:0071354;cellular response to interleukin-6;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;7.004484905440688;0.0027327542132076126;0.6813299963962409;[SBNO2, PID1, SELPLG, ST3GAL6, NFKB1, ICAM1]
GO:0010559;regulation of glycoprotein biosynthetic process;7.0;0.6634067003016617;0.6826227154080313;8.902587249109185;149.75732045160512;6.139487467954083;0.00501224274267701;0.6648930398837374;[CCL21, IL15, PAWR, IGF1, GATA1, BCL2, CCR7, CCL19, PLCB1, ITM2A, RAMP1, JAK3, HBEGF, ITM2C]
GO:0001845;phagolysosome assembly;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;81.92137458931388;8.16763571524637;0.002741834683053802;0.7686126355688037;[SRPX, CORO1A]
GO:0071353;cellular response to interleukin-4;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;6.599019797332524;0.0027327542132076126;0.6605944919115335;[ARG1, LEF1, TCF7, GATA3, CORO1A, PML, ALAD, IMPDH2, XCL1, MCM2]
GO:0014911;positive regulation of smooth muscle cell migration;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;201.77833622021802;6.280566066213989;0.0067533393245778365;0.6961884407023742;[PDGFRB, DOCK5, NRP1, DOCK4, POSTN, IGFBP5, IGF1, AIF1, P2RY6, PAK1, NR4A3, RPS6KB1, CCL5, PDGFD, BCL2, NOX4]
GO:0032469;endoplasmic reticulum calcium ion homeostasis;10.0;0.8259837884571596;0.8282329060895002;9.52844079393514;288.6919123283276;6.686031174322154;0.009662258499776054;0.7571649570480019;[CAMK2D, WFS1, PML, BCL2, GRINA, TGM2]
GO:0045190;isotype switching;12.0;0.8259837884571596;0.8611122068187244;9.517298617381897;267.39842152832483;6.943860283624253;0.00894958452559752;0.8032296504172152;[MLH1, HSPD1, MSH6, CD40LG, MSH2, EXO1, CCR6]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, CYFIP1, TFRC, CLEC10A, SLA2, MYB, TRBC1, C3AR1, UBASH3A, PGLYRP1, PRKACB, MED1, MEF2C, CXADR, PRKCH, PRKCB, PRKCE, PRKCD, SERPING1, PRKCQ, CFB, CFD, CFH, HHLA2, PRKDC, CFI, FPR1, FPR3, FPR2, GATA3, THY1, CFP, PRKCZ, SAMSN1, C2, C3, KLRK1, C7, PLCG2, HMOX1, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, ELANE, LYN, JUN, HLA-DRB4, FZD5, KIR2DS1, KIR2DS2, COL1A1, COL1A2, HLA-DRB1, DENND1B, ITK, SIGLEC9, IFIH1, CTLA4, JAK3, HLA-DPA1, HAVCR2, ANXA1, DUSP3, ARG1, IFNGR1, RIPK2, FCRL3, NFAM1, IFNGR2, PAWR, SERPINB9, PAX5, FOS, SIRT1, MMP12, FCER2, PLSCR1, RARA, TLR10, HLA-DQB1, PTAFR, UNG, NRAS, HLA-DMB, CCL19, IL12RB1, STAT1, NR1H2, CARD9, NR1H4, KIR3DL1, COL3A1, HLA-DPB1, PKN1, CLC, SIGLEC7, LGR4, PROS1, CXCL13, TNF, CLU, PYCARD, IGHG1, FCGRT, GRAP2, IL13RA2, CD177, LAG3, CD180, MSH6, CLEC4A, ADCYAP1, CLEC4D, MSH2, ADAM8, CLEC4E, S100A9, S100A8, BLK, CD274, LY96, CLEC7A, IGLV1-44, CD300LF, MAP2K6, EIF2B3, BMX, NFKB1, PTPRC, BCL6, BCL2, HLA-DRA, LAT, MYD88, ITGAM, ITGB2, PIK3CD, TREM2, PTPN22, ARRB2, ITGAL, TREM1, TNFSF13B, FCGR3A, DUSP10, ITGB7, CR2, CR1, GPX1, CHUK, ITGA4, PVRIG, LCK, XCL1, LCP2, PIK3C3, BIRC2, BIRC3, C1S, UNC93B1, C1R, NLRC3, NLRC4, NOD2, CCL5, FYN, CSK, FCGR1A, FCGR1B, FCGR2A, PTPN6, MNDA, CD247, FCGR2B, CLEC2D, IFITM1, GFI1, ICAM2, ICAM3, ICAM1, LGALS3, DHX58, ICOSLG, RSAD2, SLC11A1, HLA-B, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IL23A, BTK, TXK, STXBP2, CD1E, CD1D, CD1C, CD1B, CD1A, CD79B, CD79A, CD19, INPP5D, SLAMF7, CD14, A2M, PAG1, SH2D1A, TNFSF13, PILRA, PTK2, MARCO, CD28, CD24, CD200, IGHM, ECM1, CD40, IFNA2, CD3G, CD3E, CD3D, CTSS, RAC2, FCER1A, CTSH, MUC13, CD38, FFAR2, CTSG, CCR7, MUC15, CD36, CD34, CD33, CCR2, IL10, FCER1G, SYK, IL15, IL18, GAB2, PARP9, LIME1, VAV1, LAT2, TLR1, NCR1, HCK, CEACAM1, IL1B, KIT, IGHD, TLR8, TLR7, CD48, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA1, LILRA2, RELB, PAK1, IGKC, NPDC1, CD74, IL33, LILRB1, LILRB2, MLH1, LILRB4, CD40LG, F2RL1, C1QC, CD86, FCN1, CD80, TRAC, IL18RAP, IL6R, CD96, CD300A, THEMIS, MUC3B, OSCAR, TYROBP, CD8B, CD8A, KLRF1, CD300C, CARD11, KLRB1, C5AR1, KIR2DL1, KIR2DL2, CACNA1F, DDX60, KIR2DL3, RASGRP1, KIR2DL4, STAP1, NLRP3, LPXN, KLRC1, BTNL8, TGFB2, TGFB1, VCAM1, CAV1, CRTAM, NFKBIA, IL6, NR4A3, SELL, FES, KLRD1, IL7R, NFKBID, IGKV3-20, HMGB2, TNFAIP3, PDE4B, DDX58, MMP2, PDE4D, IRAK3, FGR, ZAP70, IFNG, LTA, IRF7, LTF, COLEC12, CLEC12B, SAMHD1, USP18, HSPD1, CNR1, HLX, TBX21, TRAT1, MAPK14, CD4, TNIP3]
GO:0010572;positive regulation of platelet activation;9.0;0.8933024483968273;0.8428918493787028;9.592156608321247;334.5200598726648;8.16763571524637;0.011196085355429928;0.8139338954918922;[SELP, PDPN, PLEK, TLR4]
GO:0030041;actin filament polymerization;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;66.55674193746657;6.409777797693995;0.0022275942554681166;0.6787156999164222;[GSN, ARHGAP6, AIF1, VIL1, PSTPIP1, HCLS1, WASF3]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB2, EPHB1, EREG, BTC, BTK, EPHA3, EPHA2, SDC2, SH2D2A, TXK, TGFA, PDGFA, PIK3R3, SLC30A10, PRKCZ, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, PILRA, IGF1, PTK2, COL1A1, NRP1, ITK, PTPRR, NRP2, CD3E, SYK, GAB1, GAB2, VAV1, HCK, KIT, PLCB1, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF1, SULF2, NCF1, NCF2, NCF4, SLA, CTGF, FGF5, EFEMP1, GRAP2, AP2M1, PDGFRB, PDGFRA, MATK, TSC2, CYBB, PDGFRL, DOK2, COL4A2, CD8B, KIF16B, COL4A1, CD8A, BLK, CSF1R, CUL5, RASGRP4, FOXO1, SOCS2, STAP1, TGFB1, CAV2, CRIM1, BMX, VIL1, GH1, NR4A3, FES, CSPG4, ITGB3, PIK3C2A, GHR, BLNK, NCBP2, MMP2, MMP9, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, SHCBP1, CD4, CD7, TEK]
GO:0022898;regulation of transmembrane transporter activity;6.0;0.5295311121456219;0.5878858686629554;7.417506353023566;24.765424706708153;4.321752512322768;8.288764774983087E-4;0.5441349370523758;[, FMR1, EPHB2, MEF2C, DAPK1, PRKCE, ACTN4, ATP1B2, PDZK1, ATP1B1, GEM, CFTR, KCNE3, TWIST1, NEDD4L, ADRB2, PLCG2, DRD4, CAV1, EHD3, FXYD2, BCL2, FXYD6, CALM3, CTSS, GRM5, JPH2, PDE4B, YWHAH, GPR35, PDE4D, MMP9, DNM2, SHANK3, NLGN1, CAMK2D, PTAFR, PLN, DMD, NEDD4, FKBP1B, GOPC]
GO:0042246;tissue regeneration;4.0;0.7586651285174919;0.629332564258746;8.935377071932177;42.88961059103013;6.039404009397101;0.0014354766683382502;0.5588554019015759;[POSTN, GSN, GPX1, TXK, CCNB1, NINJ1]
GO:0045636;positive regulation of melanocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;190.69673191605972;8.390779266560578;0.006382448001314043;0.7800242071602487;[BCL2, ADAMTS20]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[RUVBL2, TLE4, AXIN2, AES, GREM1, SFRP4, SFRP2, PFDN5, LEF1, FOXO1, FRZB, CTHRC1, FZD1, EGR1, CAV1, TMEM64, MAPK14, BMP2, DAB2, SNAI2]
GO:0070493;thrombin-activated receptor signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.976932752798508;7.57984905034425;9.028936615729279E-4;0.710754145523778;[F2R, PLEK, F2RL1, GP1BA, F2RL3]
GO:0045086;positive regulation of interleukin-2 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.292166977892469;0.027942676825076673;0.747921758369865;[CD86, IL1A, CD4, CD80, IL1B, CD28, PRKCQ, CD3E, CARD11]
GO:0048599;oocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;72.7828096339012;7.292166977892469;0.0024359751381706407;0.6631627702307852;[BCL2]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CSF3, CD80, GFI1, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, ICAM1, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, IL10, GHSR, MEF2C, ARG1, PDE4D, CD180, PDCD1LG2, TNFRSF1B, IL1B, RARA, ADAM9, IRF8, TLR4, CX3CR1, CD274, CEBPB, CEBPE, SBNO2, KLRK1, STAP1, NLRP3, CCL2, CD14, ABCA1, CCL20, NR1H2, DEFA4, NR1H4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, TNIP3, PF4]
GO:0006509;membrane protein ectodomain proteolysis;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;50.748517158788495;6.781341354126479;0.0016985071986044009;0.6977174774718518;[PSEN2, ADAM9, PRTN3, PRKCQ, RBMX]
GO:0030836;positive regulation of actin filament depolymerization;11.0;0.8259837884571596;0.845420846558242;9.503361109538115;392.2090701602175;7.212124270218933;0.013126884613015779;0.8012573229067359;[VIL1, PLEK, F2RL1]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, PGLYRP1, RNASE6, RNASE3, MIF, HLA-E, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, PRKDC, TXK, CFI, GATA3, CD1D, CFP, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, SIGLEC16, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, EIF2AK2, PTK2, MARCO, VNN1, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, RIPK2, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, LILRA5, RELB, IGKC, CARD9, NR1H4, KIR3DL1, F2RL1, LGR4, C1QC, FCN1, NCF1, NCF2, SLA, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, MATK, CYBB, CLEC4A, CLEC4D, TYROBP, CLEC4E, S100A9, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, PIK3CD, TREM2, TREM1, SIRPB1, PSTPIP1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[PPP2R1A, NEK2, TUBG1, CKAP5, PRKAR2B, CEP72, CEP76, PLK4, CEP152, PLK1, CDK1]
GO:0032696;negative regulation of interleukin-13 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;7.9853141584524145;0.002184000309729388;0.7314896500084853;[IFNA2, LEF1]
GO:0032212;positive regulation of telomere maintenance via telomerase;10.0;1.0;0.9152410118609203;9.628524252492122;1624.1830741800397;6.250713103064308;0.054359945822938814;0.734902770639515;[AURKB, NEK2, CCT8, CCT7, CCT5, CCT4, CCT3, CCT2, NEK7, CCT6A, PRKCQ]
GO:0072678;T cell migration;7.0;0.7140352122741334;0.7079369713942671;8.8813098506619;30.235634434558513;6.686031174322154;0.001011959474220325;0.692843310444282;[CXCL9, GPR15, CCL20, PIK3CD, DEFA1, CXCL16, ICAM1, CXCL10, ZAP70, CXCL11, CXCR3, CCL2, ITGB7, CCR6, CCR2]
GO:0030279;negative regulation of ossification;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.83246312675316;5.500407508664414;0.0014000948940798496;0.571532107649126;[CALCA, ECM1, TWIST1, TNF, GATA1, HOXA2, MEN1, CCR1, MEF2C, TGFB1, IGFBP5, TMEM64, AXIN2, GREM1, CDK6, ID1, BCL2]
GO:0030036;actin cytoskeleton organization;5.0;0.6347111282356054;0.607596575978723;8.048073876931273;29.6146440060229;3.9779809732199434;9.911754834323397E-4;0.49367514382642164;[F11R, TNF, ANTXR1, AQP1, POF1B, MYOZ2, PLS1, PDGFRB, MEF2A, TMOD1, PDGFRA, GAS2L3, CXADR, TPM1, DAAM2, TLN1, PFN1, S100A9, LLGL2, PDGFA, CORO1A, PRKCZ, EPB41L5, CNN1, RACGAP1, EPB41L3, MYH14, MYH11, NCKAP1L, PLEK2, MYH10, PARVB, CORO2A, CORO2B, VIL1, TBCK, ANLN, DIAPH3, BCL6, NRP1, ITGB5, PLEK, LMOD1, ARHGEF10L, CXCL1, ARRB1, EPB41L4B, ANXA1, RHOG, GAB1, RHOH, KIF23, PALLD, KIT, RHOU, DOCK2, FGD3, FGD4, PAK1, ABLIM3, FLNA, SORBS1, KRT19, DLC1, ZYX]
GO:0051754;meiotic sister chromatid cohesion, centromeric;7.0;1.0;0.8509193652572005;9.628524252492122;116.99733732322595;8.16763571524637;0.003915795589440837;0.7686126355688037;[PPP2R1A, BUB1B, BUB1]
GO:0019932;second-messenger-mediated signaling;6.0;0.6547035408479693;0.6504720830141292;8.316337863525954;26.42836680105094;4.103750360508977;8.845336528452411E-4;0.5329862968704817;[CALML4, SLC8A1, EDNRB, PPP2R1A, CCRL2, TNFSF11, PTGDR, LHCGR, ATP1B1, ADCYAP1, ADCY9, PRKAR1B, BTK, AGTR1, CALCA, CALCRL, FPR1, ITPR3, FPR2, ADRB2, PRKAR2B, PLCG2, PLCG1, CCR10, CCR1, ABCA1, VCAM1, AZU1, SELE, SELP, GNAQ, CALM3, LAT, MCTP1, LRRK2, CETN3, ADM, GRM5, CCR9, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, PTGIR, EDN1, PDE4D, AVPR1A, LAT2, MC3R, NDUFS4, CX3CR1, CAMK2D, PTGER2, CXCR5, CXCR4, CXCR6, GNAI2, PLN, CXCR1, CXCR3, CXCR2, DMD, CCL20, TSHR, FKBP1B, RAMP1, LGR4]
GO:0042532;negative regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1231.6194323740242;7.379178354882098;0.041221194016031935;0.8098004765652196;[PPP2R1A, CAV1]
GO:0008625;extrinsic apoptotic signaling pathway via death domain receptors;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;52.44533375847466;6.311337724880743;0.0017552981231601008;0.6736814700148209;[FASLG, TNF, CASP8AP2, SORT1, DAPK1, TNFRSF10B, BCL2]
GO:0051126;negative regulation of actin nucleation;12.0;0.9326813400603323;0.9144609826203107;9.59573442966913;318.2257087533811;7.697632086000634;0.010650728087431447;0.8417775754447168;[CORO1A]
GO:0032848;negative regulation of cellular pH reduction;12.0;0.9326813400603323;0.9144609826203107;9.589303539338841;367.95635365503233;9.777073627680469;0.012315168017615022;0.9481203125901445;[BCL2]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[CYFIP1, NRP1, CPNE5, CXCL16, RPS6KA1, AKT1, CD38, EDN1, AVPR1A, SFRP2, MAP1B, S100A9, S100A8, HBEGF, TAF9, LEF1, NEDD4L, PAK1, SFN, TGFB2, SYT2, FN1, IGF1, CXCL12, BCL2]
GO:0010818;T cell chemotaxis;8.0;0.8436909121759173;0.7968454560879586;9.446202695698167;127.60944988880927;7.292166977892469;0.004270973446729658;0.747921758369865;[CXCL10, CXCL9, CXCL11, CXCR3, PIK3CD, DEFA1, CXCL16, CCR2]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[CDA, NRP1, SEMA5B, CDKN1A, ARHGAP4, TCHP, PPP2R1A, HNF4A, TNR, SEMA6A, DCC, SIRT1, GREM1, PSRC1, SFRP2, NDUFS3, FBP1, RNF6, PAK1, FRZB, SPP1, APBB1, SEMA4A, TGFB2, TGFB1, CDKN2C, SEMA4B, INHBA, PML, BCL6, BCL2, SIPA1]
GO:0070560;protein secretion by platelet;9.0;1.0;0.896240625180289;9.628524252492122;143.4971776666168;9.083926447120524;0.004802721397426183;0.8607930461318132;[PLEK]
GO:0007409;axonogenesis;8.0;0.6873818243518346;0.7186909121759173;8.667113085337498;64.60914726719044;4.956792062075433;0.0021624100145753813;0.6284905765689417;[NRP1, ADARB1, STMN1, EPHB2, EPHB1, DCC, PAX2, MAP1B, CDH11, DSCAML1, SLITRK6, APBB1, LINGO1, SEMA4A, GP5, POU4F1, PTK2, NR4A2, LRFN4, OGN, BCL2]
GO:0071895;odontoblast differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;26.97430872096675;8.67846133901236;9.028058375889943E-4;0.7947362817240173;[LEF1, FAM20C]
GO:0010811;positive regulation of cell-substrate adhesion;5.0;0.7980440201809971;0.6892630219514189;9.0094850440859;35.30989762708448;5.049685808968129;0.0011817904967337807;0.5484821789659555;[DOCK5, NRP1, CYR61, EMILIN2, CCR7, EMILIN1, CD36, PRKCE, EMP2, OLFM4, DNM2, CCDC80, MMRN1, CEACAM6, NINJ1, COL8A1, THY1, NID1, PRKCZ, EPB41L5, SPOCK2, FLNA, JUP, CCL21, FN1, CDK6, TEK]
GO:0050714;positive regulation of protein secretion;8.0;0.6467165523344657;0.6983582761672329;8.730582659286164;381.48337166918856;4.304802954008995;0.01276790513702299;0.5951478232618299;[FCN1, TNF, PYCARD, CLEC5A, SOX4, WLS, POSTN, PRKCE, F2R, GOLPH3L, MIF, HLA-E, ADAM9, ADAM8, CLEC4E, CFTR, BLK, CD274, CSF1R, TWIST1, GATA3, PRKCZ, RASGRP1, TMEM27, NLRP3, CD14, MYH10, TGFB2, TGFB1, FZD5, CRTAM, IGF1, IL6, ACHE, ORM1, LRRK2, PTPN22, ARRB1, IFIH1, CD38, FFAR2, CD34, HAVCR2, IL10, CHUK, SYK, DDX58, RIPK2, IL17RB, MMP12, TLR1, FGR, IL1A, IL1B, IGHD, TLR8, TLR4, TLR2, EXOC1, NOD2, CD58, CCL19, APBB1, IL33, NR1H2, NR1H4, MAPK14, CD2, NLRP12, F2RL1, CD244, IL17A]
GO:0071899;negative regulation of estrogen receptor binding;7.0;1.0;0.8509193652572005;9.628524252492122;72.9581340598751;8.67846133901236;0.002441843088926248;0.7947362817240173;[RUVBL2, LEF1]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, COL1A2, ARHGAP6, ARHGAP4, JAK3, DUSP1, RIPK2, GMIP, SIRT1, DUSP6, PTAFR, NRAS, STAT4, DMD, STAT1, PKN1, LGR4, CTGF, SESN3, MAP3K8, KCNH1, KCNH2, CISH, CDC25C, MSH6, ADCYAP1, MSH2, BLK, LY96, SOCS2, G3BP2, TNFRSF10B, BMX, CORO2A, NFKB1, NFKB2, LRRK2, PIK3CD, FOXM1, TNFRSF1B, SPTB, LCP2, PIK3C3, LCP1, DTL, BIRC2, BIRC3, PPP1R15A, IL2RG, CCL5, E2F1, CCL2, E2F2, FYN, E2F7, SH2B1, E2F8, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, EREG, BTC, BTK, TRIB1, RIN2, EPHA2, PIK3R5, RACGAP1, CD14, PAG1, CCR1, IGF1, PTK2, CALM3, RGL4, CD24, RGL1, CD40, CETN3, BRCA1, BRCA2, CCR9, RAC2, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR3, CCR2, IL18, GAB2, LAT2, MC3R, IL1B, KIT, DEPDC1, YAP1, PCNA, GNAI2, RELB, PAK1, PERP, KITLG, FKBP1B, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, PDGFRA, DOK2, DOK3, TYROBP, CARD11, CALCA, PSEN2, RASGRP1, RASGRP4, SPTA1, CCNB1, ECT2, VCAM1, GH1, GNAQ, PLEK, TNFAIP3, GHR, GRM5, ARHGEF12, DDX58, IRAK3, MASTL, CCNA2, NDUFS4, IRF7, SHANK3, BCL2A1, AURKA, EPS8L1, EPS8L3, EGF, MAPK14, MAPK13, TEK, CYFIP1, EPS8, STMN1, CYP1B1, MED1, PRKCH, DAPK1, PRKCB, PRKCE, PRKCD, DEPDC1B, ADCY9, LGALS12, PRKCQ, PRKDC, PRKCZ, PLCG2, HMOX1, PLEK2, PLCG1, PLK2, PLK1, ITK, CDKN1A, BTG2, ADM, IFIH1, NFAM1, PAX2, CIT, HCLS1, PLCB1, HBEGF, EXOC1, GSN, CCL20, CARD9, POU4F1, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, IGFBP5, DGKZ, NRBP1, RAB32, MELK, RAB31, CSF1R, DNMT1, CALCRL, CUL5, ITPR3, RASAL2, MAP2K6, DHCR24, BCL6, CNOT3, BCL3, CDK2, CDK1, BCL2, CSPG4, LAT, BCL2L1, PIK3C2A, TREM1, TLK1, GPX1, CHUK, TFDP1, IL3RA, CX3CR1, CEBPB, NLRC3, NOD2, RAB21, PLN, PML, DNAJA3, CALML4, EDNRB, PPP2R1A, CHEK1, RPS6KA1, SOX4, PTGDR, TIAM2, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, EDN1, STRADB, RHOG, RHOH, AVPR1A, GFRA3, VAV1, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, GUCY2C, SP100, PTGER2, CXCR5, CXCR4, CXCR6, AIF1, CXCR1, CXCR3, CXCR2, PDPN, MLH1, CAMK4, CAMK1, SIPA1, SIRPG, ARHGDIA, ARHGDIB, TSC2, ATP1B1, CSF2RB, ADRB2, CSF2RA, TGFB1, SELE, NFKBIA, SELP, ARHGAP30, JMY, DOCK5, GPSM2, DOCK4, MCTP1, CXCL1, TMEM100, BLNK, CASP2, PTGIR, PDE4D, TGFBR3, ZAP70, DOCK2, CAMK2D, NCAM1, TSHR, PIKFYVE, RPS6KB1]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, CSF3, IFNA2, ARRB1, ARRB2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, RIPK2, MIF, SFRP2, IFNG, HCLS1, IFNA10, PTGS2, PAK1, NTF3, IFNA21, SNCA, TGFB1, CAV1, LIF, OSM, IL6, BCL2, CAMK1]
GO:0050849;negative regulation of calcium-mediated signaling;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;240.2984816065916;6.518977089658987;0.008042573924779611;0.7083807915285978;[PLEK, SLA2, FKBP1B, HOMER3, CALM3]
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;52.930841574252625;6.943860283624253;0.001771547632825523;0.7060287030842711;[GPX1, PRKCD, PML, MELK, BCL2, CYP1B1]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[CDKN1A, BCL2A1, PRKDC, BRCA1, BRCA2, TNF, PYCARD, E2F1, HMOX1, CASP2, SFN, MLH1, TNFRSF1B, SIRT1, PML, MSH6, MSH2, BCL3, BCL2, EPHA2, BCL2L1]
GO:0021943;formation of radial glial scaffolds;6.0;1.0;0.8231203125901445;9.628524252492122;47.452274261266446;8.390779266560578;0.0015881849152503491;0.7522251544931926;[LEF1, FLNA]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, ETS1, SLC8A1, AQP1, IL18RAP, MYB, CYP1B1, PDGFRB, ANXA1, GPX1, DUSP1, ARG1, PRKCD, SIRT1, PAX2, ADAM9, HDAC2, PCNA, KCNA5, FOXO1, CST3, PDGFD, HMOX1, ECT2, JUN, STAT1, KLF4, MAPK13, COL1A1, FABP1, FOSL1, IL6, NR4A3, FKBP1B, CDK1, BCL2, SDC1, EZH2]
GO:0051134;negative regulation of NK T cell activation;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;304.9258485151261;9.083926447120524;0.010205593734354167;0.8797934328124444;[CD300A]
GO:0032713;negative regulation of interleukin-4 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.96654663153603;7.9853141584524145;0.002174371849661483;0.7314896500084853;[CD83, LEF1]
GO:0007416;synapse assembly;4.0;0.8436909121759173;0.6718454560879586;9.117698628726131;35.85243951974866;5.500407508664414;0.0011999488856252476;0.5312910957882058;[ACHE, NLGN1, FZD5, PLXND1, PCDHB15, PCDHB14, PCDHB10, POU4F1, CDH1, SPOCK2, PCDHB16, SLITRK6, PCDHB4, SHANK3, PCDHB8, SDK2]
GO:0032714;negative regulation of interleukin-5 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;7.8311634786251565;0.002184000309729388;0.7236063770733796;[IFNA2, LEF1]
GO:0001558;regulation of cell growth;5.0;0.5833093054345528;0.5818956645781967;7.6590836060266145;26.25041167864861;3.793137346993279;8.785776550476476E-4;0.4842222321850823;[CDA, CYFIP1, CPNE5, KIAA1109, PPP2R1A, DPYSL2, RPS6KA1, AKT1, SFRP2, MAP1B, AGTR1, PRKCQ, NEDD4L, EPB41L3, SFN, FN1, IGF1, FXYD2, NRP1, CDKN1A, KIF14, ARHGAP4, ESM1, HNF4A, CD38, EDN1, AVPR1A, SIRT1, IL17RB, CEACAM1, SGK1, HBEGF, PAK1, FRZB, SPP1, APBB1, CDKN2C, KIF26A, SIPA1, SEMA5B, CTGF, CXCL16, TNR, SEMA6A, IGFBP5, CISH, IGFBP3, S100A9, S100A8, HTRA1, SOCS2, IGFBP7, TGFB2, TGFB1, SYT2, CRIM1, INHBA, CXCL12, BCL6, BCL2, CYR61, TCHP, MYOCD, DCC, DNM2, GREM1, PSRC1, NDUFS3, FBP1, CAMK2D, TAF9, LEF1, RNF6, RAB21, SEMA4A, SEMA4B, PML]
GO:2000648;positive regulation of stem cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;63.968874315823136;6.250713103064308;0.002140980655101363;0.6427820713687392;[CX3CR1, SMARCD3, LTBP3, ASPM, PTPRC, EPCAM]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, CD40, TFRC, TNFSF13B, CD38, NCKAP1L, CD74, MEF2C, FCRL3, MIF, MSH6, BST1, PTPRC, BCL6, BCL2, CARD11, CD320]
GO:0031069;hair follicle morphogenesis;4.0;1.0;0.75;9.628524252492122;21.56700107071243;6.518977089658987;7.21828116795923E-4;0.5833807915285978;[TGFB2, IGFBP5, BCL2]
GO:0010389;regulation of G2/M transition of mitotic cell cycle;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;58.92720908338202;4.74012102526684;0.001972240656975688;0.6174100096703167;[PPP2R1A, NEK2, CDC25C, CDC25A, MSH6, BLM, HMMR, CCNB1, PRKAR2B, RAD21, CEP72, NAE1, CLSPN, CEP76, FANCI, PLK4, PLK1, CDC7, CDC6, TPX2, CDK6, CDK2, CDK1, KIF14, BRCA1, TOPBP1, TUBG1, CKAP5, RAD51C, DTL, SMARCD3, VPS4B, AURKB, AURKA, CEP152, DONSON, CENPF]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[PTPN22, DUSP10, PPP2R1A, NUP62, DUSP2, DUSP3, DUSP1, CD300A, PAQR3, PRKCD, IRAK3, DUSP6, SFRP2, IL1B, LYN, CAV1, PTPN6]
GO:0014042;positive regulation of neuron maturation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;592.6446807852996;8.390779266560578;0.019835284120298998;0.8253454670833372;[BCL2]
GO:1904355;positive regulation of telomere capping;9.0;0.9326813400603323;0.8625812952104552;9.59462270081644;613.4505056642549;6.943860283624253;0.02053163635497091;0.7513499630073597;[NEK7, PRKCQ, NEK2, AURKB]
GO:0060305;regulation of cell diameter;6.0;1.0;0.8231203125901445;9.628524252492122;29.63014819255531;9.777073627680469;9.916943946027175E-4;0.8231203125901445;[PLEK]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, PRKDC, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, FOSL2, FOSL1, HOXC10, DLGAP5, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, ZEB1, TAL1, RARA, HCLS1, ENG, NR1I2, EPCAM, STAT4, STAT1, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, SBNO2, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, FOXM1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, UHRF1, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, CCNC, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, IGF1, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RELB, RXRA, APBB1, IL33, CDX1, OSM, LILRB1, GRHL2, F2RL1, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL2, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, IRF8, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, TNIP3, RBMX]
GO:0043401;steroid hormone mediated signaling pathway;6.0;0.7508913569872202;0.6985659910837546;8.801845679307654;25.735219620490994;4.909539177224887;8.613346405038622E-4;0.5741943744303455;[TGFB1I1, FHL2, HNF4G, RORA, BRCA1, NR3C2, HNF4A, YWHAH, MED1, CCNE1, RARA, PADI2, YAP1, NR1I2, LEF1, RXRA, VDR, NR1H2, NR1H4, DEFA1, NR2F2, NR4A2, NR4A1, NR4A3, NEDD4, RAN]
GO:0048539;bone marrow development;5.0;1.0;0.7902410118609202;9.628524252492122;32.5184652959493;7.697632086000634;0.001088363768736683;0.6838982747154925;[PTPRC, HOXB4]
GO:0040018;positive regulation of multicellular organism growth;6.0;1.0;0.8231203125901445;9.628524252492122;145.45792876686207;6.280566066213989;0.004868345972189967;0.6443087532925187;[GHSR, GHR, VIL1, GH1, BCL2, PLS1]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, BTG2, KIF14, ARRB1, ARRB2, CHL1, MEF2C, F2R, MSH2, ADAM8, NAIP, CEBPB, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, HMOX1, FYN, SNCA, JUN, WFS1, GABRA5, SOD2, POU4F1, NR4A2, NR4A3, BCL2, BCL2L1]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[SLC46A2, PRKDC, GATA3, CCNB2, HOXA3, BCL11B, MAFB, BCL2, MAD1L1]
GO:0050850;positive regulation of calcium-mediated signaling;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;239.92176968958296;6.039404009397101;0.008029965715936047;0.6838554019015759;[TREM2, CD3E, TNF, JPH2, CCL4, SYK, TRAT1, IGF1, ZAP70, P2RX5, CD4, CALM3]
GO:2000417;negative regulation of eosinophil migration;9.0;0.8933024483968273;0.8428918493787028;9.533214072687796;296.2025090399906;9.083926447120524;0.009913631412617212;0.8607930461318132;[CD300A]
GO:0030889;negative regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.3396801226706;7.004484905440688;0.016946733417578675;0.7544503089863854;[LYN, IL10, TNFRSF13B, CD300A, PAWR, INPP5D, BTK, CTLA4, MNDA, PKN1, FCGR2B]
GO:0051023;regulation of immunoglobulin secretion;8.0;0.8933024483968273;0.8216512241984136;9.523163736834295;116.24681071054106;6.943860283624253;0.0038906761391443723;0.7301093378270707;[IL33, IL6, CD40, CD40LG, TNF, HLA-E]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, ADM, TNF, AQP1, ICAM1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, FECH, ABCB4, PTAFR, PTGS2, TYMS, AIF1, FOXO1, IGFBP7, TGFB1, FOSL1, IL6, RPS6KB1, BCL2, ALPL, SDC1, FOSB]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[TNC, IHH, FHL2, CYR61, FBL, AKT1, JUNB, MEF2C, TPM4, IGFBP5, IGFBP3, RUNX2, VCAN, COL6A1, EPHA2, LEF1, HSD17B4, TWIST1, GPNMB, FIGNL1, SPP1, HSPE1, COL1A1, BMP2, PSMC2, ALPL, SNAI2, RBMX, LGR4]
GO:0050859;negative regulation of B cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;309.61561130321576;7.9853141584524145;0.010362555874359037;0.7833693374183408;[CD300A, FCRL3, LPXN, PTPN6]
GO:0050856;regulation of T cell receptor signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.461470167828956;68.86251036091213;6.193554689224359;0.0023047662495439825;0.6676580400938822;[PTPN22, THY1, CACNA1F, LGALS3, CCR7, UBASH3A, DUSP3, TRAT1, PVRIG, CD300A, PAWR, LILRB4, CEACAM1, LCK, PTPN6]
GO:0050857;positive regulation of antigen receptor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.52844079393514;294.8408907598327;6.7325511899570465;0.00986805927415722;0.6952223462072524;[LYN, PRKCH, TRAT1, PRKCB, NFAM1, PTPRC, LCK, STAP1, CCR7]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, PIK3CD, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, RIPK2, PDE4D, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, TXK, GATA3, THY1, PAK1, INPP5D, PLCG2, FYN, CSK, PLCG1, HLA-DQA2, HLA-DQA1, PAG1, BTNL8, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, NFKBID, LAT, HLA-DRB1]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[, BLK, IGHM, ITK, TXK, PIK3CD, CD79B, CD79A, IGHG1, IGKC, CD19, TRBC1, PLCG2, CTLA4, CD38, NCKAP1L, IGHA1, LYN, MEF2C, SYK, PRKCB, BMX, LIME1, LAT2, PTPRC, LCK, BTK, IGHD, BCL2, PTPN6, MNDA]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, LGALS1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, MAP3K8, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD5, CD28, PTPN6, CD24, CARD11]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[CCNF, HERC5, SKP2, FBXW2, CDC34, NEDD4L, BARD1, HACE1, UBE2C, MARCH1, UBE2S, UBE2T, BCL2, TNFAIP3, BRCA1, UBE2Q2, RNF144A, RNF144B, DTL, BIRC2, RNF6, ZNRF1, RNF24, NEDD4]
GO:0048305;immunoglobulin secretion;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;133.331941423656;8.390779266560578;0.004462500088492957;0.8253454670833372;[CD40LG, TNFSF13B]
GO:0046488;phosphatidylinositol metabolic process;7.0;0.6835726970475526;0.6927057137809769;8.801845679307654;147.2037350013595;4.383446081328108;0.004926776535734991;0.5750890017074093;[CD86, CD80, SLA2, FGF5, PDGFRB, PDGFRA, CISH, TTC7B, EREG, BTC, PLBD1, CSF1R, PDGFA, PIK3R3, PIK3R5, SOCS2, CD19, INPP5D, PLCG2, PIP5K1B, ICOS, BMX, SYNJ1, CD28, PLEK, PIK3CD, PIK3C2A, IMPA1, IMPA2, GAB1, VAV1, LCK, KIT, PIK3C3, PLCB1, HBEGF, FYN, TRAT1, EGF, MBOAT7, KITLG, PIKFYVE]
GO:0006672;ceramide metabolic process;7.0;0.7140352122741334;0.7079369713942671;9.176539128749065;101.21355503378848;5.420364800990877;0.0033875266006951925;0.628117073252615;[GAL3ST1, SGMS1, GBA3, FUT3, FUT7, GM2A, PPP2R1A, ITGB8, P2RX1]
GO:0035094;response to nicotine;4.0;0.9326813400603323;0.7163406700301662;9.446202695698167;26.17342148764107;5.926926025970411;8.760008626412986E-4;0.5531032725983739;[CHRNB4, EDN1, HDAC2, VCAM1, SLC7A11, TNF, NFKB1, CNR1, BCL2, HMOX1]
GO:0061502;early endosome to recycling endosome transport;6.0;1.0;0.8231203125901445;9.628524252492122;50.18376484494501;9.083926447120524;0.001679605446904144;0.7876727335416686;[CORO1A]
GO:0001782;B cell homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;22.00128503895464;6.599019797332524;7.363632103827933E-4;0.6883935445785896;[LYN, MEF2C, TNFRSF13B, TNFAIP3, TNFSF13B, BCL2, NCKAP1L, PKN1]
GO:0001541;ovarian follicle development;4.0;1.0;0.75;9.628524252492122;34.608406302298;6.166155715036245;0.001158312213394382;0.5653374900225189;[CEBPB, INHBA, FANCG, ICAM1, ADCYAP1, KIT, CTNNA1, BCL2, MMP19, BCL2L1]
GO:0001662;behavioral fear response;5.0;1.0;0.7902410118609202;9.628524252492122;37.889479621082295;6.375876246018314;0.0012681267845998157;0.6163036195908642;[GABRA5, DPP4, ADCYAP1, RPS6KB1, BCL2, DRD4]
GO:0051279;regulation of release of sequestered calcium ion into cytosol;9.0;0.7369933605727446;0.7647373054666613;9.242861771680136;148.50473241193134;5.486614186532078;0.004970319748245178;0.676826329833192;[CXCL9, CAMK2D, THY1, CORO1A, SLC8A1, JPH2, PLN, CD19, DMD, PLCG1, SNCA, LYN, TGFB1, TRPC1, PRKCE, PDE4D, F2R, CXCL10, CXCL11, FKBP1B, XCL1, PTPN6, CALM3, F2RL3]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TFRC, ICAM1, TNFSF11, TRIM25, MYBL2, TLE4, PCOLCE, SIRT1, PADI2, SBNO2, SPOCK2, LAPTM5, KLF4, PML, BSPRY, KLF5]
GO:0010925;positive regulation of inositol-polyphosphate 5-phosphatase activity;10.0;1.0;0.9152410118609203;9.628524252492122;315.02421328910475;9.777073627680469;0.010543576915400974;0.9152410118609203;[PLEK]
GO:0001658;branching involved in ureteric bud morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.015873511986907;0.0017907488225476112;0.6585714164269392;[PAX2, HOXA11, GREM1, BMP2, BCL2]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, IL1RN, CSF3, SPARC, CD80, GFI1, SERPINE1, CXCL13, MPO, LOXL1, ICAM1, PYCARD, EDNRB, JUNB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, TRIB1, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, SBNO2, KLRK1, PLCG2, STAP1, NLRP3, S100A14, CD14, ELANE, ABCA1, JUN, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, NFKB2, SELP, CXCL10, CXCL11, IL6, ALPL, CD27, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, ADM, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, IL10, PTGIR, EDN1, CHUK, ARG1, PDE4D, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, RARA, IRF8, TLR4, CX3CR1, CEBPB, HDAC2, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, SNCA, GCH1, CCL20, NR1H2, IL10RA, NR1H4, LILRB1, LILRB2, MAPK14, CD6, RPS6KB1, TNIP3, LTBR, PF4]
GO:0010920;negative regulation of inositol phosphate biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.59462270081644;802.7961320943956;9.777073627680469;0.026868864071587235;0.875;[PLEK]
GO:0070528;protein kinase C signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;7.212124270218933;8.845336528452411E-4;0.6919486831672181;[PRKCH, PLEK, AZU1, PRKCZ]
GO:0021879;forebrain neuron differentiation;6.0;0.7980440201809971;0.722142322680643;9.0094850440859;26.729186262933762;7.069023426578259;8.946018095145202E-4;0.6846304993685643;[CSF1R, BCL11B, LEF1, INHBA, SHANK3]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, JUNB, HOXA5, SOX4, MEF2A, MED1, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, TXK, GATA3, GATA1, NHLH2, RAD21, EGR1, EGR2, JUN, BCL11B, FOSL2, FOSL1, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, PLSCR1, TFEC, SATB2, FLNA, CDX2, CDX1, GTF2H1, GRHL2, POU4F1, FOSB, TRIP13, CCNT2, ARID4A, ETS1, HOXA10, PTTG1, LMO2, C5AR1, HMGA1, NFKB1, NFKB2, COPS5, MAFB, FEV, MAFF, ARRB1, ARRB2, MYBL2, MYBL1, MYOCD, KLF13, NCBP2, ETV1, TFDP1, ELF3, IRF7, CREB5, CEBPA, CEBPB, CEBPD, CEBPE, TAF9, LEF1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF6, KLF5, POU2AF1, TAF5, RBMX]
GO:0002320;lymphoid progenitor cell differentiation;5.0;0.8653626801206646;0.7229223519212526;9.223059144383958;22.164838071467113;7.379178354882098;7.418371831928127E-4;0.6676125360964777;[SPI1, PRKDC, KIT, BCL2, GATA3, SOX4]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[TGFB1, SLC46A2, TNFSF14, RIPK2, CACNA1F, CORO1A, CCNB2, SIT1, BCL2, NCKAP1L, JAK3]
GO:0002685;regulation of leukocyte migration;7.0;0.5577261244500507;0.6297824274822259;8.169909229792605;50.8327261637902;4.6122876537569555;0.0017013255982186238;0.586791970363642;[ITGA2B, SERPINE1, CXCL13, TNF, ICAM1, PYCARD, LGALS3, C3AR1, HOXA7, IL6R, IL1R1, CD300A, MIF, IL23A, PADI2, ADAM8, NBL1, C5AR1, FPR2, THY1, PLA2G7, KLRK1, PDGFD, STAP1, HMOX1, NCKAP1L, S100A14, ELANE, LYN, CCR1, TGFB1, TNFSF14, PPBP, SELP, BST1, CXCL10, CXCL11, IL6, CXCL12, GPR18, CXCL6, CXCL9, ECM1, CXCL1, CXCL3, CXCL2, CXCL5, MMP28, RAC2, CCR7, EMILIN1, CCR6, CCR2, EDN1, ANXA1, ITGA4, GREM1, IL1A, IL1B, XCL2, XCL1, PLCB1, PTAFR, THBS1, AIF1, CCL8, CCL7, CCL5, CXCR3, CXCR2, CCL4, CCL2, CCL1, CCL19, JAM3, MPP1, CD74, IL33, CCL21, CCL20, MAPK14, F2RL1, PF4]
GO:2000318;positive regulation of T-helper 17 type immune response;8.0;0.8933024483968273;0.8216512241984136;9.56398573135455;171.5773823021682;7.474488534686424;0.005742540576034618;0.7572456912631272;[IL23A, NLRP3, PRKCQ, IL12RB1, NFKBID]
GO:0043392;negative regulation of DNA binding;5.0;0.7586651285174919;0.6695735761196662;8.866384200445225;32.533753988449135;5.788089581116195;0.0010888754675157227;0.5862441822128946;[SP100, HDAC2, LEF1, GATA1, E2F1, HMOX1, NEK2, JUN, GZMA, NFKBIA, ID1]
GO:0002438;acute inflammatory response to antigenic stimulus;6.0;0.7671156992804218;0.7066781622303554;9.117698628726131;43.66651068845287;7.57984905034425;0.0014614788154342952;0.710754145523778;[CD6, CXCR2, GATA3, ELANE, ICAM1]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[TNFAIP8, ARRB1, ARRB2, AQP1, LAMP3, RPS6KA1, AKT1, GPX1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, BIRC2, BIRC3, LEF1, IFI6, NLRC4, PTGS2, THBS1, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4, FABP1, VIL1, CD27]
GO:0051209;release of sequestered calcium ion into cytosol;14.0;0.7980440201809971;0.874941375347699;9.527428135620752;522.9340415463636;5.9928839937622085;0.01750213176047399;0.7823957313958061;[CCL21, PRKCE, F2R, FASLG, ITPR3, JPH2, PTPRC, LCK, FKBP1B, PLCG2, XCL1, CCR7, CCL19, CCR5]
GO:0048041;focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;92.53238439646684;6.599019797332524;0.0030969756320103773;0.712474179321389;[ACTN1, PTPRK, SORBS1, THY1, ARHGAP6, DLC1, BCL2]
GO:0030223;neutrophil differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;48.172706276873754;8.390779266560578;0.0016122971264660058;0.7800242071602487;[CSF3, LEF1]
GO:2000570;positive regulation of T-helper 2 cell activation;11.0;1.0;0.9324289523296623;9.628524252492122;326.26765218285163;9.777073627680469;0.010919884696736623;0.9324289523296623;[PRKCQ]
GO:0007223;Wnt signaling pathway, calcium modulating pathway;9.0;1.0;0.896240625180289;9.628524252492122;33.206889128170424;6.250713103064308;0.001111404694859899;0.7159023839588838;[FZD2, FZD5, LEF1, PLCB1]
GO:1900740;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;990.0589542238915;6.599019797332524;0.033136382202663156;0.7527151911823093;[GZMB, TFDP1, TP53BP2, E2F1, BCL2, SFN, YWHAH]
GO:0021861;forebrain radial glial cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;23.8388145050385;7.8311634786251565;7.978636679434658E-4;0.7236063770733796;[LEF1]
GO:0038180;nerve growth factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;27.195621953761602;7.292166977892469;9.102129923216596E-4;0.7238411236270654;[SORT1, NTF3, CORO1A]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[ITK, PIK3CD, CD3G, PTPN22, RORA, CD3E, CD3D, CCR9, CCR6, SOX4, EOMES, ANXA1, FCER1G, RSAD2, RHOH, RUNX2, VAV1, ZAP70, CLEC4D, LCK, CD8A, KIT, CLEC4E, BLM, PRKDC, TXK, LEF1, TCF7, GATA3, RELB, FUT7, TBX21, NKX2-3, EGR1, SEMA4A, TGFB1, BCL11B, FZD5, FZD8, BMX, CD4, PTPRC, MAFB, DNAJA3, BCL3, CD28, BCL2, IL7R, GPR18, IL18R1]
GO:0030216;keratinocyte differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;25.58801435984686;5.486614186532078;8.564078129062366E-4;0.6037060172430475;[DSP, YAP1, MED1, ST14, CSTA, JAG1, ANXA1, EREG, ADAM9, EPHA2]
GO:0032516;positive regulation of phosphoprotein phosphatase activity;10.0;0.8653626801206646;0.8479223519212526;9.5525383455142;1089.2705050571928;6.832634648514029;0.036456903524454846;0.7646622655359331;[PDGFRB, PPP1R15A, PPP1R12A, CD300A, FCRL3, CALM3]
GO:0010507;negative regulation of autophagy;7.0;0.7436939687323844;0.7227663496233927;9.117698628726131;217.48068666745357;5.500407508664414;0.007278882862848883;0.6322104610454062;[LRRK2, PTPN22, AKT1, TSC2, HMOX1, SNCA, PTK2, BCL2]
GO:0046671;negative regulation of retinal cell programmed cell death;7.0;0.9326813400603323;0.8172600352873667;9.584072489921288;304.76275982415854;9.777073627680469;0.010200135302637775;0.8509193652572005;[BCL2]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, PTPN22, TNF, CCL5, AKT1, CCL2, CD14, LYN, TGFB1, RIPK2, PRKCE, IL18, MAPK14, NFKBIA, HCK, CD6, IL1B, TLR4, TLR2]
GO:0001915;negative regulation of T cell mediated cytotoxicity;9.0;0.8933024483968273;0.8428918493787028;9.557065288509976;365.562885098783;7.9853141584524145;0.012235060779019208;0.8046099625986299;[CEACAM1, PTPRC, LILRB1, FCGR2B, IL7R]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, PRKCH, PRKCB, PRKCE, PRKCD, VRK1, PRKCQ, PRKDC, PRKCZ, CCNB1, CLSPN, PLK2, PLK1, CDC7, CLK1, CDK2, CDK1, BCL2, LRRK2, MAP4K1, CHUK, SYK, MASTL, SGK1, CAMK2D, TTK, AURKB, AURKA, MAPK14, MAPK13, RPS6KB1, CAMK4, PKN1, CAMK1]
GO:0032753;positive regulation of interleukin-4 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;6.686031174322154;0.0021737836760178982;0.665044257777226;[CD86, IL33, CEBPB, PRG2, GATA3, CD3E, PRKCZ, HLA-E, CD40LG, CD28, RARA, NLRP3, PRKCQ, HAVCR2]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[LRRK2, CHEK1, AKT1, PRKCB, PRKCD, CAD, VRK1, CAMK2D, TTK, CLK1, CDK1, BCL2, PKN1, CAMK1]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[IL1RN, IFITM1, SERPINE1, ADARB1, CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, IGFBP5, CD300A, IGFBP3, TPM1, MIF, SFRP2, PADI2, TRIB1, NBL1, VCL, TACSTD2, THY1, KLRK1, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, CXCL12, BCL2, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, GREM1, TMEFF2, PLCB1, ENG, CX3CR1, SP100, LRP1, THBS1, AIF1, CCL2, IL33, CCL21, TIE1, PODN, KLF4, SULF1, COL3A1, DLC1]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[SPARC, SERPINE1, MYLK, ICAM1, LGALS3, C3AR1, AKT1, IL1R1, PRKCE, ACTN4, IL23A, PFN1, KIF20B, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, IGF1, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, ANXA1, ANXA3, GAB1, SIRT1, F3, IL1A, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, AIF1, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CD74, CCL21, CCL20, F2RL1, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, ETS1, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, POSTN, SEMA6A, IGFBP5, F2R, ADAM9, ADAM8, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, VIL1, CXCL10, CXCL11, IL6, BMP2, DAB2, CXCL12, PTPRC, NR4A3, BCL2, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, PIK3CD, LAMC2, CXCL1, CXCL3, PIK3C2A, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL2, XCL1, LEF1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, SEMA4A, EGF, SEMA4B, LAMB1, MAPK14, SOD2, RPS6KB1, TEK]
GO:0043967;histone H4 acetylation;12.0;0.8259837884571596;0.8611122068187244;9.464221201200845;659.4528027923784;5.825829909099042;0.022071291840469662;0.7460535250702665;[LEF1, BRCA2, RUVBL2, RUVBL1, APBB1, ACTL6A, ELP4]
GO:0043966;histone H3 acetylation;12.0;0.7671156992804218;0.8316781622303555;9.3498108500231;659.4528027923784;5.926926025970411;0.022071291840469662;0.7512235851885185;[SPI1, TAF9, LEF1, ELP4, BRCA2]
GO:0006582;melanin metabolic process;5.0;0.811012628672052;0.6957473261969462;9.318369324188282;72.72537912965618;7.212124270218933;0.002434052990877658;0.659069382437994;[TRPC1, BCL2]
GO:0006469;negative regulation of protein kinase activity;10.0;0.6835726970475526;0.7570273603846966;9.223059144383958;1097.0598301796;4.243684138952949;0.03671760522636433;0.6322632160784685;[ADARB1, PYCARD, PPP2R1A, AKT1, EPHB2, MEN1, CISH, CD300A, PAQR3, PRKCD, TSC2, SFRP2, PRKAR1B, TRIB1, THY1, SOCS2, FLRT2, PRKAR2B, SFN, LYN, GADD45B, CAV1, PLK1, NR2F2, PTPRC, CDK6, GNAQ, PKIG, CDKN1A, LRRC4, TNFAIP3, PTPN22, HHEX, DUSP10, LRRTM4, NUP62, DUSP2, MYOCD, DUSP3, DUSP1, BGN, IRAK3, GP1BA, SIRT1, DUSP6, DCN, CEACAM1, IL1B, CEBPA, LRRC19, CDKN2C, PODN, PTPN6, PKN1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, ZEB1, TAL1, RARA, HCLS1, ASCL2, STAT1, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CDK2, CIITA, FHL2, FASLG, FOXM1, HHEX, RFC1, PEG3, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, E2F8, PRRX1, KLF4, KLF8, KLF5, DNAJA3, GFI1, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H2, SUV39H1, BMI1, XPO1, CD36, HBZ, EDN1, PARP9, IL1B, SP100, SATB2, RELB, RXRA, APBB1, CDX2, LILRB4, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TIMELESS, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, IRF8, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0010718;positive regulation of epithelial to mesenchymal transition;6.0;0.811012628672052;0.7286266269261705;9.377209824211215;170.70262580884207;5.9928839937622085;0.005713263263432726;0.6295966787287501;[HDAC2, TGFB1I1, LEF1, TWIST1, LOXL2, EPB41L5, PDPN, TGFB2, TGFB1, AXIN2, COL1A1, BMP2, DAB2, IL1B, EZH2, ENG]
GO:0030326;embryonic limb morphogenesis;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;43.30626768056369;5.395046993006588;0.0014494218061579028;0.5661439659786197;[LEF1, TWIST1, AFF3, HOXC10, HOXA11, HOXA10, MED1, TGFB2, PRRX1, RUNX2, GREM1]
GO:0002534;cytokine production involved in inflammatory response;3.0;0.9326813400603323;0.6644609826203107;9.405380701177911;21.07076093796092;8.67846133901236;7.052194061398546E-4;0.6419372290569613;[CD96, SEH1L]
GO:0045595;regulation of cell differentiation;4.0;0.3376379861120121;0.41881899305600606;5.249000748036359;23.33457331431992;2.3564947222696686;7.809871690777242E-4;0.3705112496850823;[SPI1, KIAA1109, DPYSL2, AKT1, PGLYRP1, MEF2A, MEF2C, SPINT1, AGTR1, MYL9, GATA3, THY1, ADAMTS12, GATA1, EPB41L5, SFN, LYN, ABCA1, JUN, JAG1, FN1, EIF2AK2, COL1A1, EZH2, ARHGAP4, CTLA4, JAK3, RIPK2, EMP2, FOS, SIRT1, DUSP6, PTGS2, FRZB, NTF3, CLPTM1, SPP1, FLNA, IL12RB1, STAT1, TMEM64, COL3A1, RORA, CTGF, EFEMP1, HLA-DOA, ATP11C, OLFM4, ADCYAP1, S100A9, TACSTD2, FOXO1, SOCS2, GPR98, NFKB1, CXCL10, CXCL12, LRRK2, ITGB3, ARRB2, ADAMTS20, BIRC2, LRP1, LRP2, E2F1, FYN, CTHRC1, LINGO1, PRRX1, USH2A, PTPN6, FCGR2B, CPNE5, CDC20, LGALS3, LGALS1, TNFSF11, EPHB2, EPHB1, PAQR3, HNF1B, ACTN4, EREG, BTC, SFRP4, SFRP2, BTK, TRIB1, KIF20B, EPHA3, SDC2, CCR1, MSR1, EGR3, TNFSF14, IGF1, PTK2, ID1, CD28, CD27, CD24, NRP1, CTSZ, KIF14, CD38, CD36, CD34, CCR2, CD53, SYK, IL15, IL18, RGMA, IL1B, KIT, YAP1, PAK1, CD74, SORT1, TMEM176B, TMEM176A, XK, NEDD4, FKBP1B, IL17A, FOXA2, SCARB2, CD86, CD83, CD80, MPL, IHH, ETS1, LOXL2, IL6R, EOMES, PDGFRA, TYROBP, CARD11, RASGRP1, ECT2, SYT2, VDR, CAV1, ISG15, INHBA, IL6, BMP2, COL5A1, GNAQ, COL5A2, TCF4, IL7R, FBN1, HMGB2, CA2, YWHAH, MYOCD, GREM1, IRF7, SHANK3, RNF6, AURKA, CNR1, TBX21, SPOCK2, RBM38, MAPK14, SOD2, CD2, CD4, ACIN1, CYFIP1, SERPINE1, HOXA9, MYB, GPR171, HOXA2, HOXA7, JUNB, HOXA5, MED1, PRKCH, PRKCB, DAAM2, MAP1B, LGALS12, HOXB4, HOXB3, PRKCQ, NEDD4L, PRKCZ, FLRT2, PRDM16, NCKAP1L, FZD1, NFE2, PLK2, SNAI2, TGFB1I1, ADM, TIMP2, ANXA1, FCRL3, NFAM1, PAX2, ZEB1, TAL1, RARA, HCLS1, PLCB1, ENG, ASCL2, CCL19, NR1H2, POU4F1, PF4, SEMA5B, CSF3, CSF3R, PLXND1, FMR1, ITGA2B, TNF, CDH5, TNR, MEN1, LHCGR, SEMA6A, IGFBP5, IGFBP3, ADAM8, DNMT1, HOPX, DAB2, MAFB, CDK6, BCL6, SYNJ1, MAFF, CDK1, BCL2, PLXNB2, CYR61, LBH, DUSP10, CR1, ASPM, ASPA, CX3CR1, CEBPA, NLGN1, CEBPB, HDAC2, SMARCD3, RAB21, SEMA4A, SEMA4B, IRX3, KLF4, KLF5, EVI2B, IFITM1, SLC46A2, GFI1, EDNRB, PPP2R1A, RPS6KA1, FLT3LG, HLA-G, RUNX2, POR, IL23A, SIK1, NBL1, TWIST1, INPP5D, BCL11B, LIF, VNN1, ITM2C, ROBO2, IFNA2, EDN1, GP1BA, NME1, CEACAM1, CEACAM5, FAM20C, TLR4, TLR2, CXCR4, PDPN, CTNNA1, APBB1, CDX2, LILRB1, LILRB2, LILRB3, GRHL2, LILRB4, CAMK4, CAMK1, C1QC, HOXA11, ARHGDIA, POSTN, LMO2, FANCD2, FBLN1, LTBP3, STAP1, NLRP3, TGFB2, TGFB1, NFKBIA, LIN28A, NR4A3, FES, NFKBID, DOCK5, CXCL9, TMEM100, KLF13, DCC, AXIN2, DNM2, ZAP70, IFNG, LTA, PDE5A, LTF, HEMGN, LEF1, DLL1, THBS1, HLX, S1PR3, S1PR5, MEIS2, MEIS1, PMP22]
GO:0001569;branching involved in blood vessel morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.375876246018314;0.0017907488225476112;0.6769819729871445;[NRP1, EDN1, PLXND1, LEF1, IHH, EDNRA, SFRP2, COL4A1, ENG]
GO:0032740;positive regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.23665507211369;7.212124270218933;0.002183412136085803;0.6919486831672181;[TGFB1, IL23A, IL15, IL18, PRKCQ, NOD2, LY9, MYD88]
GO:0060070;canonical Wnt signaling pathway;8.0;0.6729672293956388;0.7114836146978194;8.391761625343195;31.415129658942366;5.233778845410465;0.0010514361179036673;0.6426556935498979;[LRRK2, LEF1, TCF7, GATA3, CDH3, FRZB, SOX4, FZD1, FZD2, FZD5, EGF, FZD8, TMEM64, KLF4, NR4A2, SFRP4, HOXB9, SFRP2, SDC1, SNAI2, LGR4]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[PROS1, SERPINE1, SPINT2, AQP1, PTTG1, LAMP3, RPS6KA1, AKT1, APLP2, POR, SFRP2, SPINT1, SLPI, SERPING1, NAIP, C3, SFN, A2M, TNFSF14, TNFRSF10C, CRIM1, TNFRSF10B, DHCR24, VIL1, CD27, TNFAIP8, SERPINA1, ARRB1, ARRB2, TIMP2, TIMP3, TIMP1, CR1, SERPINB2, GPX1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, COL6A3, BIRC5, BIRC2, LTF, BIRC3, SERPINB10, CSTA, LEF1, IFI6, NLRC4, PTGS2, CST7, THBS1, CST3, SPOCK2, SPOCK3, SNCA, KLF4, FABP1]
GO:0034125;negative regulation of MyD88-dependent toll-like receptor signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;9.083926447120524;0.011871713162238609;0.8607930461318132;[CD300A, CD300LF]
GO:0051902;negative regulation of mitochondrial depolarization;8.0;1.0;0.875;9.628524252492122;107.5075323722012;7.8311634786251565;0.003598180358000013;0.7754860644832351;[IFI6, BCL2]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[PTPRR, PTPN22, PTPRK, DUSP10, DUSP2, DUSP3, DUSP1, CDC25C, DUSP6, CDC25A, TPTE, PTPRE, PTPRC, PTPN6, PTPN7, PTPN4, CDKN3]
GO:0031532;actin cytoskeleton reorganization;6.0;1.0;0.8231203125901445;9.628524252492122;32.01253927882412;5.788089581116195;0.001071430880247358;0.6191234829421188;[NRP1, PLEK, ANTXR1, PRKCZ, PAK1, FLNA, CXADR, ANXA1, GAB1, PARVB, KIT, S100A9]
GO:0033033;negative regulation of myeloid cell apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.360260265897443;105.01969455662797;7.069023426578259;0.003514914665221449;0.7365101867784198;[GHSR, FCER1G, CCL5, CXCR2, CLEC5A, IRF7, BCL2, MIF, NOD2, CCR5]
GO:0033153;T cell receptor V(D)J recombination;11.0;1.0;0.9324289523296623;9.628524252492122;333.8668407979641;8.16763571524637;0.011174222700858697;0.8501222226412654;[BCL11B, PRKDC, LEF1, TCF7]
GO:0006470;protein dephosphorylation;7.0;0.7586651285174919;0.7302519295159464;9.223059144383958;177.1697810635027;4.458953633836253;0.005929713129744359;0.5789504614541361;[PPP2R1A, CDC25C, CDC25A, PTPRE, PTPRC, BCL2, PTPRR, PTPN22, PTPRK, DUSP10, DLGAP5, DUSP2, PPP1R12A, DUSP3, DUSP1, DUSP6, LCK, PPP1R15A, TPTE, CPPED1, PPP1CA, PTPN6, PTPN7, PTPN4, CDKN3]
GO:0034241;positive regulation of macrophage fusion;7.0;1.0;0.8509193652572005;9.628524252492122;142.40946411816813;8.67846133901236;0.0047663166038382455;0.7947362817240173;[ADAM9]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[NUP107, SPI1, SLA2, SPIB, AKT1, MNX1, ATF3, CDCA7, GATA3, GATA1, JUN, JAG1, JUP, EIF2AK2, NR2F2, DHFR, PKIG, HOXC10, CHAF1B, DLGAP5, FOS, MMP12, MED23, PLSCR1, PTAFR, SPP1, ZNF467, CASP8AP2, ATAD2, NOC3L, CENPF, PKN1, LGR4, GMNN, EFEMP1, BLM, G3BP2, ZNF423, CIITA, ITGB2, HHEX, UHRF1, CDC45, E2F1, E2F2, E2F5, E2F7, E2F8, POU2AF1, SMARCAL1, IKZF1, ICAM1, TNFSF11, TRIM25, FBXO5, BTK, TRIB1, TGFA, PKHD1, BRIP1, EGR1, EGR2, EGR3, IGF1, POLA1, ECM1, IL10, SYK, IL18, IL1A, IL1B, KIT, DEPDC1, YAP1, PCNA, RELB, IL33, OSM, ETS1, NR3C2, LOXL2, CARD11, TCF7, HTRA1, LPXN, CAV1, UBA3, TCF4, MXD1, FBN1, PHTF2, PLEK, TNFAIP3, LYL1, MYBL2, MYBL1, MYOCD, NUP133, IRAK3, ETV1, GREM1, ELF3, ZMYND11, FBP1, RNF6, TBX21, RRM2, CD4, TNIP3, PHB2, PRKCH, PRKCB, PRKCQ, PRKDC, PRKCZ, NUP85, PRDM16, HMOX1, NFE2, PLK1, FOSL2, FOSL1, SNAI2, CDKN1A, BTG2, ZNF367, HELLS, ZEB1, RARA, NR1I2, ASCL2, EPCAM, NR1H2, NR1H4, ELP4, FOSB, PF4, CSF3, PLXND1, TNF, CLU, TLE4, MAP2K2, AEBP1, MAP2K6, DAB2, COPS5, BCL6, BCL3, CCDC22, SLC26A3, PTTG3P, CYR61, LBH, EMILIN1, RFC1, TFDP1, XCL1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, NLRC3, NLRC4, NOD2, ABLIM3, POLR2K, POLR2L, PML, DNAJA3, PPIL4, GFI1, PPP2R1A, RPS6KA1, FLT3LG, NIF3L1, IL23A, SIK1, NBL1, TXK, TWIST1, LIF, TOP2A, AHCTF1, IFNA2, PRL, XPO1, HBZ, EDN1, PARP9, CBFA2T3, VAV1, MLF2, HCK, TLR6, TLR4, TLR2, TYMS, PURA, APBB1, GRHL2, CD40LG, F2RL1, HOXA11, HOXA10, LMO2, FANCD2, TIMELESS, NLRP3, CBX4, KDM5D, SLC40A1, H2AFX, DCN, DNM2, PFDN5, LTF, LEF1, HLX, SNCA, LUM, RBMX, PID1, EHMT2, MEF2A, WDHD1, MEF2C, ZFYVE16, PADI2, PADI4, HESX1, MCTS1, HACE1, COL1A1, EZH2, RIPK2, ACTL6A, SIRT1, PSMA6, CKS2, FSTL1, BTAF1, STAT4, FLNA, STAT1, USP9Y, PSMC6, PSMC2, CCNT2, NCF1, RORA, RUVBL2, RUVBL1, ADCYAP1, S100A9, S100A8, MAZ, TNFRSF11A, FOXO1, SBNO2, NFKB1, NFKB2, CXCL10, MYD88, FHL2, FASLG, ARRB1, ARRB2, FOXM1, PPP1R12A, PEG3, BIRC5, BDP1, BIRC2, LRP2, ZBTB41, PRRX1, CCNH, CCNC, UXT, TMPO, HNF1B, EREG, SFRP4, SFRP2, IFI27, PCBP3, ZNF700, OR7D2, ID1, CD28, SUV39H2, CD40, SUV39H1, HNF4G, PTPRK, BRCA1, BRCA2, PCSK6, BMI1, CD3D, HNF4A, CD38, CD36, RGMA, SATB2, RXRA, CD74, NLRP12, NEDD4, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, EOMES, CCNE1, CALCA, VDR, HMGA1, INHBA, IL6, BMP2, HMGB2, ARHGEF10L, AFF3, NUP62, YWHAH, DDX58, CCNA2, PSRC1, IRF7, IRF8, CREB5, TAF9, AURKB, EGF, MAPK14, SOD2, MAPK13, NUP35, TAF5, NAA15, RAN, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, CYP1B1, HOXA7, JUNB, HOXA5, HOXA4, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB6, HOXB5, ASF1B, NEDD4L, RAD21, S100A12, ELANE, NKX2-3, FZD1, FZD2, FZD5, FZD8, CDC6, TGFB1I1, HAVCR2, TCF19, BRD2, ANXA3, NFAM1, PAWR, PAX5, PAX2, AES, TAL1, HCLS1, PLCB1, ENG, GTF2H1, SULF1, POU4F1, PYCARD, DACH1, CDH1, MEN1, F2R, ADAM8, DNMT1, NACC2, WFS1, HOPX, MAFB, CNOT3, MAFF, CDK2, CHUK, TRAF1, SMARCD3, RBBP8, ZNF503, IRX3, KLF4, KLF1, KLF8, KLF6, KLF5, MNDA, ZNF608, EDNRB, CHEK1, DPF3, SOX7, SOX4, SLC11A1, EBF1, RUNX2, PFN1, BEX1, SP140, NHLH2, CDT1, BCL11B, BCL11A, RHOG, RHOH, MDFIC, TFEC, SGK1, SP100, CDX2, CDX1, LILRB1, LILRB4, CAMK4, CAMK1, ARID4A, ARID4B, CHCHD3, PTTG1, BASP1, ADRB2, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, JMY, NFKBID, CREBZF, CKS1B, TMEM100, KLF12, KLF13, CKAP2, TGFBR3, IFNG, CAMK2D, DLL1, HSPD1, MEIS2, MEIS1]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[IL1RN, ADM, PRL, ETS1, THBD, CD38, TGFB1, IGFBP5, CAD, FOS, FOSL1, ADCYAP1, CLDN4, PNOC, RARA, BCL2, FOSB]
GO:0048864;stem cell development;4.0;0.8436909121759173;0.6718454560879586;9.34084218004034;32.15320660831846;6.375876246018314;0.001076138889173156;0.576062607729944;[EDN1, JAG1, EDNRA, PTPRC, SNAI2]
GO:0048743;positive regulation of skeletal muscle fiber development;9.0;1.0;0.896240625180289;9.628524252492122;623.8299612915386;7.697632086000634;0.02087902739391249;0.7898978880348613;[BCL2]
GO:0007569;cell aging;3.0;0.7980440201809971;0.597142322680643;8.935377071932177;24.751975343904395;5.618190544320798;8.284263394289076E-4;0.485434838299289;[CDKN1A, SERPINE1, BRCA2, ICAM1, NUP62, CHEK1, MME, PRKCD, H2AFX, HMGA1, MIF, MAPK14, SIRT1, PML, DNAJA3, CDK1, BCL2, NOX4, ENG]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[PID1, SPI1, EHMT2, SLA2, SPIB, AKT1, MNX1, MEF2A, WDHD1, MEF2C, ZFYVE16, ATF3, GATA3, GATA1, HESX1, JUN, JAG1, JUP, NR2F2, PKIG, EZH2, HOXC10, DLGAP5, RIPK2, ACTL6A, FOS, SIRT1, MMP12, MED23, PLSCR1, CKS2, PTAFR, FSTL1, STAT4, ZNF467, STAT1, USP9Y, ATAD2, NOC3L, PSMC6, PSMC2, PKN1, CCNT2, RORA, RUVBL2, RUVBL1, ADCYAP1, MAZ, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, FASLG, ARRB1, FOXM1, HHEX, PPP1R12A, PEG3, UHRF1, LRP2, ZBTB41, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, POU2AF1, SMARCAL1, CCNH, CCNC, IKZF1, UXT, TNFSF11, HNF1B, SFRP4, SFRP2, IFI27, TGFA, BRIP1, PCBP3, ZNF700, EGR1, EGR2, EGR3, IGF1, ID1, CD28, SUV39H2, ECM1, CD40, SUV39H1, HNF4G, BRCA1, PCSK6, BMI1, CD3D, HNF4A, CD36, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RELB, RXRA, IL33, OSM, NEDD4, FOXA3, IL17A, FOXA2, IHH, ETS1, NR3C2, LOXL2, EOMES, CCNE1, TCF7, HTRA1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, MXD1, FBN1, PLEK, HMGB2, ARHGEF10L, LYL1, MYBL2, MYBL1, MYOCD, DDX58, ETV1, GREM1, ELF3, IRF7, IRF8, ZMYND11, FBP1, CREB5, TAF9, AURKB, TBX21, MAPK14, SOD2, TNIP3, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, PRKCB, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB6, HOXB5, PRKDC, NEDD4L, RAD21, PRDM16, HMOX1, ELANE, NKX2-3, FZD1, NFE2, FZD5, PLK1, FZD8, FOSL2, FOSL1, SNAI2, CDKN1A, BTG2, ZNF367, HAVCR2, TCF19, BRD2, PAWR, PAX5, PAX2, AES, ZEB1, TAL1, RARA, HCLS1, ENG, NR1I2, ASCL2, EPCAM, NR1H2, NR1H4, GTF2H1, ELP4, SULF1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, NACC2, WFS1, HOPX, COPS5, MAFB, BCL6, MAFF, BCL3, CDK2, CYR61, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, RBBP8, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, DNAJA3, PPIL4, GFI1, ZNF608, EDNRB, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, IL23A, PFN1, NBL1, BEX1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, LIF, TOP2A, AHCTF1, PRL, XPO1, HBZ, EDN1, PARP9, TFEC, TLR4, TLR2, SP100, PURA, APBB1, CDX2, CDX1, LILRB1, GRHL2, LILRB4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, PTTG1, LMO2, TIMELESS, ADRB2, NLRP3, TGFB2, TGFB1, CBX4, NR4A2, NFKBIA, NR4A1, NR4A3, FEV, JMY, NFKBID, CREBZF, KDM5D, SLC40A1, TMEM100, KLF12, KLF13, CKAP2, DCN, TGFBR3, IFNG, CAMK2D, LEF1, DLL1, HSPD1, HLX, SNCA, LUM, MEIS2, MEIS1, RBMX]
GO:0048747;muscle fiber development;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;33.944966077546525;5.75172193694532;0.001136107466129388;0.6172636399279519;[CXADR, GPX1, CAV2, LEF1, XK, MYH11, DMD]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[CXCL13, SLC8A1, EDNRA, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, TGM2, PDGFRA, PRKCE, F2R, ADCYAP1, AGTR1, CALCA, C5AR1, FPR1, FPR3, ITPR3, FPR2, THY1, CD19, HRH4, PLCG2, PLCG1, CCR10, CCR1, CAV1, CXCL10, CXCL11, PTPRC, CALM3, CD24, GPR18, CXCL9, FASLG, ADM, JPH2, CCR9, CD38, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, CD52, PTGIR, EDN1, TRPC3, GPR35, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, PTGER2, CXCR5, CXCR4, CXCR6, GNA15, CXCR1, CXCR3, CXCR2, S1PR3, CCL1, CCL19, GPR157, SNCA, CCL21, GPR6, P2RX5, CD4, FKBP1B, F2RL1, F2RL3]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[CD40, HSPD1, CCR7, CD36, CCL19, RIPK2, MAPK14, HLA-G, CD40LG, IFNG, IL23A, IRF8, LTB, PLCB1, TLR4, TLR2]
GO:0030318;melanocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;22.857985252022832;6.8867018697843045;7.650361955340501E-4;0.6424272657460779;[MEF2C, EDNRB, KIT, BCL2]
GO:0048753;pigment granule organization;5.0;0.8436909121759173;0.712086467948879;9.223059144383958;20.915744831851537;6.518977089658987;7.000311565738116E-4;0.623621803389518;[RAB32, BCL2]
GO:0048873;homeostasis of number of cells within a tissue;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;26.75021374699733;6.444869117505266;8.953055804826206E-4;0.6527112189764278;[F2R, FLT3LG, CORO1A, GATA1, BCL2, CCR2]
GO:0051232;meiotic spindle elongation;4.0;1.0;0.75;9.628524252492122;45.03457221597044;9.777073627680469;0.0015072666035848682;0.75;[PPP2R1A]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, PRKDC, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, HCLS1, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, DNMT1, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, GPX1, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, IGF1, PTK2, VNN1, ID1, CD28, CD27, NRP1, KIF14, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, CASP2, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, AURKA, SNCA, SOD2, RPS6KB1, TEK, NAA15]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CX3CR1, CXCL6, CCL13, CXCL9, CXCR5, MPL, CXCR4, CXCL1, CXCR6, CXCL13, CXCL3, CXCL2, CXCL5, CCL8, CXCR1, CCL7, CCL5, CXCR3, CXCR2, CCRL2, CCL4, CCR9, CCL2, CCL1, CCR7, CCR6, CCL19, CCR5, CCL18, CCR10, CCR3, CCR2, CCR1, CCL23, CCL21, CCL20, GPR35, PPBP, CXCL10, CXCL11, CXCL12, XCL2, XCL1, PF4]
GO:0006904;vesicle docking involved in exocytosis;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;32.65265176272962;6.039404009397101;0.0010928548690198408;0.6319757144917204;[STXBP2, PLEK, CFTR]
GO:0071864;positive regulation of cell proliferation in bone marrow;6.0;1.0;0.8231203125901445;9.628524252492122;63.05258358394898;7.9853141584524145;0.0021103132289136558;0.7314896500084853;[MEF2C, LEF1, FLT3LG]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[NCF2, ITGB3, NCF4, ICAM3, ITGAL, CD36, TGM2, ANXA1, CD93, ANXA3, SLC11A1, DNM2, PECAM1, RARA, IRF8, PRTN3, CD302, LRP1, CEBPE, PLD4, CORO1A, CD14, ELANE, SLAMF1, CDC7, MARCO]
GO:0032733;positive regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.375876246018314;0.002183412136085803;0.6491829203200885;[CD274, CD83, FCER1G, NOD2, PRKCZ, HSPD1, PYCARD, CD40LG, IL23A, BCL3, CD28, XCL1, TIGIT, TLR4, CD34, TLR2]
GO:0071866;negative regulation of apoptotic process in bone marrow;8.0;1.0;0.875;9.628524252492122;103.9210822679579;8.390779266560578;0.0034781451006065307;0.8041048419030481;[PLK2, LEF1, FLT3LG]
